Next Article in Journal
Bromodomain Protein Inhibitors Reorganize the Chromatin of Synovial Fibroblasts
Next Article in Special Issue
Embryonic Ethanol but Not Cannabinoid Exposure Affects Zebrafish Cardiac Development via Agrin and Sonic Hedgehog Interaction
Previous Article in Journal
Establishment of Skeletal Myogenic Progenitors from Non-Human Primate Induced Pluripotent Stem Cells
Previous Article in Special Issue
Development of a Triple-Negative Breast Cancer Leptomeningeal Disease Model in Zebrafish
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Bioelectricity in Developmental Patterning and Size Control: Evidence and Genetically Encoded Tools in the Zebrafish Model

by
Martin R. Silic
1 and
GuangJun Zhang
1,2,3,4,*
1
Department of Comparative Pathobiology, Purdue University, West Lafayette, IN 47907, USA
2
Center for Cancer Research, Purdue University, West Lafayette, IN 47907, USA
3
Purdue Institute for Inflammation, Immunology and Infectious Diseases (PI4D), Purdue University, West Lafayette, IN 47907, USA
4
Purdue Institute for Integrative Neuroscience, Purdue University, 625 Harrison Street, West Lafayette, IN 47907, USA
*
Author to whom correspondence should be addressed.
Cells 2023, 12(8), 1148; https://doi.org/10.3390/cells12081148
Submission received: 4 March 2023 / Revised: 3 April 2023 / Accepted: 10 April 2023 / Published: 13 April 2023
(This article belongs to the Special Issue Modeling Developmental Processes and Disorders in Zebrafish)

Abstract

:
Developmental patterning is essential for regulating cellular events such as axial patterning, segmentation, tissue formation, and organ size determination during embryogenesis. Understanding the patterning mechanisms remains a central challenge and fundamental interest in developmental biology. Ion-channel-regulated bioelectric signals have emerged as a player of the patterning mechanism, which may interact with morphogens. Evidence from multiple model organisms reveals the roles of bioelectricity in embryonic development, regeneration, and cancers. The Zebrafish model is the second most used vertebrate model, next to the mouse model. The zebrafish model has great potential for elucidating the functions of bioelectricity due to many advantages such as external development, transparent early embryogenesis, and tractable genetics. Here, we review genetic evidence from zebrafish mutants with fin-size and pigment changes related to ion channels and bioelectricity. In addition, we review the cell membrane voltage reporting and chemogenetic tools that have already been used or have great potential to be implemented in zebrafish models. Finally, new perspectives and opportunities for bioelectricity research with zebrafish are discussed.

1. Introduction

Embryonic development is a self-autonomous and robust process in which a new body develops from a fertilized egg. This developmental process requires coordinated and complex cellular events such as proliferation, differentiation, and movement. The related patterning mechanisms are essential and instructive elements that eventually guide the body shape and organ sizes [1,2,3]. The morphogen gradient and transcription network are the mainstay theories and have been verified in many organ systems of various organisms [4,5,6]. Recent and past evidence revealed that ion-channel-related bioelectricity is a new component of the regulating mechanism for developmental patterning, regeneration, and cancers [7,8].
Bioelectricity is defined as endogenous electrical signaling across cell membranes and is mediated by the dynamic distribution of charged molecules [7,8,9,10,11,12,13]. This is represented by a difference in the net charge of cations and anions inside versus outside a cell. Many components are involved in electrical potential formation [12,14]. In essence, the semipermeable lipid-based plasma membrane acts as an electrical insulator, but also as a capacitor that can accumulate charge, while specialized passages (ion channels, pumps, connexins/gap junctions, and solute carriers) regulate ion flow from one side to the other, altering the voltage of the cell (Figure 1A). All cell types form ionic gradients across their cell membranes because channels exist throughout all living organisms in all domains of life, including plants, fungi, and bacteria [14,15,16,17,18,19,20,21,22,23,24]. Thus, ion regulation and the resulting bioelectricity are considered essential properties of living cells across evolution, and their innate properties can be used for cellular communication [25,26]. Therefore, understanding additional aspects of bioelectricity in cells and organisms is fundamental for modern physiology and ontology.
Neuronal and muscular systems have been well investigated for their bioelectric activities. The field of neuromuscular bioelectricity has a relatively long and diverse history [27]. Luigi Galvani first demonstrated the relationship between electricity and animals in 1780 by electrically stimulating frog limbs to cause movement. However, it was almost another hundred years before the first measurements of action potentials, in 1865 by Julius Bernstein, using a differential rheotome [28]. The first intracellular electrical measurements of the resting membrane in the protozoon Paramecium were performed in 1934 [29]. Afterward, ion discoveries on neuronal bioelectricity were made by Hodgkin and Katz, using the giant squid axon as an experimental model [30]. Their intracellular recording studies paved the way for neurology and the fundamental understanding of action potentials [31]. One example is the combinational uses of neuronal axons’ action potential, voltage-gated Ca2+ ion channels, and synaptic neurotransmitters for neural signals [32]. However, the function of bioelectricity remains largely unknown outside of a neuromuscular context. Expanding on these concepts of neuronal bioelectricity and neurotransmitters, it is not inconceivable that other electrical signals could travel across the membranes of non-nerve cells and trigger various responses: to cause other ions to enter the cell (or be released from internal stores); to change transcriptional regulation of the machinery; to cause protein modifications, such as conformation or phosphorylation, to affect function; as well as to modify plasma membrane molecules such as receptors, kinases, and lipids [33,34,35,36]. Indeed, recent advances in bioelectricity research regarding embryonic development, regeneration, cancers, and potential mechanisms have been systematically reviewed [8,37,38]. In this review, we will focus on zebrafish mutants with patterning defects and genetic tools that are related to bioelectricity.

2. Cellular Contributors to Membrane Potential and Bioelectricity

2.1. Cell Membrane Potential and Concentration Gradients

Bioelectricity can be exhibited in several different forms in multicellular organisms: on cellular, tissue, and organ levels. For example, cell membrane potential or membrane voltage (Vm) is one of the integral cellular bioelectric properties (Figure 1A). Many essential cellular physiological processes rely on Vm. These include cross-membrane transport (e.g., nutrients, salts, water), cell volume control, secretion, the cell cycle, and migration [13,25]. Additionally, Vm allows for cognitive and motor function through neuronal signaling, resulting in organismal, tissue, or cellular sensory detection, and locomotive movement [25].
In typical neuronal signaling, the steady-state baseline voltage is called resting Vm, whereas the excited “signaling” state is called an action potential (AP). The resting cell membrane potential is the overall combination of ions for a cell, but the equilibrium potential for each ion is different in different cell types [25], resulting in a range of resting membrane potentials in each cell type (Table 1). Although this generally results in a range between −30 and −80 mV, Vm can even exceed a range of −5 mV to −150 mV, depending on cell type [9]. These resting Vm values can fluctuate in a small or large deviation. Large and rapid depolarization changes from negative to more positive membrane potential are referred to as APs, which are barely reported outside of neuronal and muscular tissues. These APs are triggered by ion channels that respond to changes in voltage that reach a certain threshold. More specifically, depolarizations may merge along a neuron axon or dendrite, eventually pass the Vm threshold for voltage-gated ion channels, and form an AP [39]. These AP waves can propagate from multiple locations, and if two meet from opposing directions, they will annihilate each other [40]. This quick (millisecond) and extreme (≥100 mV difference) swing in voltage, caused by altering intracellular ion concentrations, is unique to excitatory cells. However, increasing evidence shows smaller and longer-duration types of electrical signaling events in other, non-excitable cell types, such as melanocytes, can have significant effects [41]. Changes in Vm of non-excitable somatic cells could come from a variety of factors and would not be classified as traditional AP signals (Figure 1B). Smaller and less extreme increases or decreases in Vm can occur within embryonic neural and non-neural tissues over various periods, such as milliseconds, seconds, minutes, hours, or even days. Such subtle bioelectric signals may be essential in cell differentiation and embryonic patterning during development [7,8,9,37].
The electromagnetic force of the differential distribution of ions across the cell membrane generates the electric potential. Thus, the concentration gradient of each ion molecule jointly contributes to Vm value [63]. For example, there is a high level of potassium (K+) and low levels of sodium (Na+) within cells at resting Vm. High levels of intracellular K+ and extracellular Na+ ions are mainly established by the sodium/potassium ATPase pump (Figure 1A). One ATPase pump binds three intracellular Na+ ions, utilizes ATP to change conformation via phosphorylation, and releases the three Na+ ions into the extracellular space. Next, two extracellular K+ ions will bind to this outward-facing conformation, causing dephosphorylation and reversal of conformation that allows potassium ions into the cell against its concentration gradient [7,64]. This form of active transportation and the resulting electrochemical gradient is responsible for high intracellular potassium.
The electrical potential difference that counteracts or balances the concentration gradient for a given ion is called equilibrium potential. If only one permeant ion species exists in a cell, its resting membrane potential will equal the equilibrium potential for that ion. Potassium and sodium ions are the two main contributors to membrane potential, but Cl and Ca2+ ions can also affect Vm, in addition to other charged molecules, such as protons (H+) and organic anions, depending on cell types. Generally, potassium equilibrium potential is close to resting cell membrane potential in many cell types, including glia and neurons. Thus, maintenance of high intracellular potassium is critical for establishing resting Vm [32,63]. This difference in concentration is hard to maintain, and potassium ions can exit the cell through various leak channels, such as K2P potassium channels on the plasma membrane [65]. Removing positively charged K+ ions from the cell will result in a more negative electrical charge, forcing more positive ions to be pulled back into the cell against the chemical gradient. This constant cycling of potassium being pumped into cells and leaking out helps to establish the electric potential of resting Vm. Eventually, these electric and gradient forces will reach equilibrium. This balance can be mathematically described in the Nernst equation [32,63].

2.2. Membrane Potential Contributors: Ion Channels, Gap Junctions, and Solute Carriers

Ion channels are a group of transmembrane proteins that significantly contribute to overall cellular bioelectricity. Channels are essentially small pores in the cell membrane that alter permeability for specific ions based on selectivity (molecular charge and size) and gating (what is required to open the channel) [66]. Channel conductivity is aligned with the ion concentration gradient, so energy is not required for a high rate of ion-selective transport. However, the channels will only allow ions to flow down their concentration gradient (moving from high to low concentration areas). The composition of these channels on the cell membrane has been compared to an electronic component called a field-effect transistor [67]. In the human genome, more than 400 family members of ion channels are currently characterized, accounting for around 1.5% of the genome [68]. A comprehensive list of human ion channel details can be found on the HUGO Gene Nomenclature Committee website and the IUPHAR/BPS Guide to Pharmacology [66,69].
Based on ion selectivity, ion channels can be classified as sodium (Na+), calcium (Ca2+), potassium (K+), chloride (Cl), or proton (H+) channels, as well as non-charged molecules such as aquaporins [66,70]. The most direct Vm-contributing ion channels are K+ and Na+, while the others play a minor role or secondary messenger role, such as that of Ca2+. Each ion channel type can then be further categorized by gating mechanism. One group, voltage-gated channels, will open or close when their voltage-sensitive domains detect a specific change in membrane potential, usually a significant depolarization from action potentials in neurons. Another type, ligand-gated ion channels, relies on their receptor binding a particular ligand to cause or prevent ionic flow. A third category, leak channels, continually allows a small amount of sodium or potassium to leave the cell, regardless of Vm state [65,71,72]. This type of channel can profoundly impact Vm because it can heavily affect the ion gradient at different stages of excitatory conditions. There are additional mechanisms to regulate or gate leak channels, such as temperature, mechanical force, and light [65,71,72]. Another interesting group of channels is that of inwardly rectifying potassium channels (Kir) [73]. These channels allow K+ ions to move more easily into, rather than out of, a cell when the cell membrane is depolarized. This is because the intracellular concentration of potassium is so high at rest, and this type of ion movement occurs against the concentration gradient. Even when these are functioning, it is difficult for K+ ions to enter the cell, and they might leak out. Due to this unique characteristic, the Kir channels will impact concentration gradients, resting membrane potential, and cell excitability [73]. Furthermore, different channels can show distinct levels of rectification (e.g., high or low). The lipid species, such as PIP2 (phosphatidylinositol 4,5-bisphosphate), can further regulate Kir channels, as can Mg2+, polyamines, phosphorylation, or protein–protein interactions [73].
Gap junctions are membrane proteins that physically connect adjacent cells to allow ions, small molecules, and electrical impulses to pass directly by a regulated gate between cells. Like ion channels, their conductance is passive and down an electrochemical gradient. Thus, they do not rely on ATP-like ion pumps. Gap junctions are formed by connecting proteins called connexins and pannexins in vertebrates and innexins in invertebrates (depending on the number of Cys residues in their extracellular loop and glycosylation) [74]. These connexins have unique protein structures, properties for permeability, and gating. Each gap junction comprises six connexin subunits on one cell that oligomerize with another six connexins on an adjacent cell. The connection of the same connexin isoform is called homogenous/homomeric, but these properties can change and become more complex by forming heterogeneous/heteromeric gap junctions [75]. When these connexins are not coupled to form a gap junction, they are known as hemichannels [76]. These hemichannels may serve as an ionic and molecular interchange routes between the cytoplasm and the extracellular environment [77]. Gap junctions and hemichannels play significant roles in cell-to-cell communication by exchanging ions, small molecules, subcellular vesicles, electric impulses, and organelles, due to their relatively larger pores [78]. Thus, they are natural modulators of cellular bioelectricity. Electrical synapses between neurons can be considered a specialized gap junction. In addition, gap junctions have also been found to be needed for direct cell communication in tunneling nanotubules (TNTs) [79,80]. Gap junctions are crucial for many physiological processes, including synchronized depolarization of cardiac muscle and embryonic development [81,82]. One ubiquitous gap junction, connexin 43 (CX43), has been implicated in multiple organisms and diseases and it contributes to electrical signaling [83]. Connexin mutations and misregulations have been shown to cause many diseases, such as neurodegenerative diseases and congenital morphological defects in mice and humans [84,85].
Another group of Vm ion regulators is solute carrier proteins (SLCs). These proteins utilize secondary active transport, where thermodynamically favorable reactions (i.e., ions moving down their concentration gradient) are paired with one or more other molecules to be transported in an unfavorable reaction [86]. The free energy provided by the movement in the favorable direction makes movement in the less favorable direction possible and allows transport without directly consuming cellular energy. These reactions utilizing the electrochemical gradient can occur with both substrates moving in the same direction, known as symporters, or substrates moving in opposite directions, known as antiporters. Thus far, over 450 transporter proteins are found in the plasma membrane of cells and subcellular organelles [86,87,88]. These SLCs have an extensive range of substrate specificity, including ions, organic ions, sugars, vitamins, amino acids, nucleotides, oligopeptides, drugs, and metals. In addition, some SLCs can transport multiple different biomolecules, others can only transport a single biomolecule, and up to 30% are “orphan” proteins, whose substrates remain unknown. Thus, these SLCs have been involved in many physiological regulations, such as selective barriers, neurotransmitters, nutrition, and metabolic regulation [86,88]. More than 190 diseases have been linked to SLCs, such as thyroid, hearing, neurological, metabolic, and congenital defects [86,88]. Due to the nature of their substrates, the SLCs could be an essential contributor to cellular bioelectricity.

3. Bioelectricity Evidence from Zebrafish Genetics

3.1. Zebrafish as a Superior Model for Bioelectric Research

The zebrafish has become one of the leading model organisms used in research since its debut in the 1970s, due to its unique advantages [89,90,91]. First, zebrafish share vertebrate biology with humans. Zebrafish possess 70% orthologous genes to humans [92]. Second, it is a relatively affordable model, compared to murine models. Third, small body size and external development make zebrafish embryos an ideal in vivo system. Fourth, tractable genetics has been developed in zebrafish, including large-scale forward genetic mutagenesis, CRISPR-based reverse genetics, and Tol2 transposon-based transgenesis [93,94,95]. Furthermore, a significant source of mutation lines is available through the repository ZFIN, and the greater zebrafish research community is highly collaborative [96,97]. All these advantages make zebrafish popular for studying developmental biology, neuroscience, physiology, toxicology, drug screens, and many human diseases such as cancers [89,90,91,98,99]. Zebrafish are also particularly suited to bioelectric research. The combination of excellent and well-established genetic tools with transparent external embryonic development can allow for manageable mutant generation and cutting-edge microscopy to explore previously unattainable information. These attributes can also be useful in bioelectric research. Below, we highlight bioelectric-related zebrafish studies that demonstrate the importance of this model as an optimal way to characterize and uncover the as-yet-undetermined bioelectric characteristics and mechanistic properties.

3.2. Zebrafish Mutants with Adult Fin-Size Change

Zebrafish adults have two sets of fins: paired fins (pectoral and pelvic) and unpaired median fins (dorsal, anal, and caudal), aligning their anterior to posterior body margins [100,101,102]. Each fin comprises endoskeletons and external dermal bones: the fin rays, or lepidotrichs. The adult fin size and its proportion to the body are generally unvarying. Zebrafish paired fin development was reported to share similar mechanisms with tetrapod limbs, as corresponding signaling centers such as ZPA (zone of polarization) and AER (apical ectodermal ridge) were characterized in zebrafish [100,103,104]. Although direct evidence of bioelectricity in zebrafish fin development is still lacking, indirect evidence came from several zebrafish fin mutants from large-scale forward genetic screenings. These mutants display either elongated or short fins, and underlying mutated genes are involved in normal ion regulation via channel, solute carrier, or connexin (Table 2), indicating that bioelectricity, not a specific ion regulator, is the key to zebrafish fin patterning and size regulation.
The first reported zebrafish mutant with elongated fin size is longfin(loft2), which is a dominant mutant that occurred in nature and is present in the widely used Tüpfel fish line. The causal mutant gene of the lof has remained unknown for decades until recently. Two independent reports pinpointed Kcnh2a, a voltage-gated potassium channel [105,106]. There is a 0.9 Mb chromosomal reversion upstream of the kcnh2a gene on chromosome 2 [106]. This inversion disrupts gene regulation and causes a change of the cis-ectopic expression of kcnh2a in zebrafish fins. Similar to the loft2, another longfin (alfdty86d), an ENU-induced mutant, possesses elongated fins in adults in a dominant way [107]. This alfdty86d mutant was reported to be caused by gain-of-function mutations in kcnk5b, a potassium leak channel gene [107]. The authors also reported larva fish overgrowth and cellular voltage change, indicating the Kcnk5b-mediated bioelectricity of fin anlagen could be the underlying mechanism through local overgrowth [107].
The schleier is another zebrafish mutant with elongated fins. This mutation is caused by the inactivation of a potassium–chloride cotransporter, slc12a7a/kcc4a [108]. This mutant is also genetically dominant, and homozygous adults exhibit broken stripes and pigmentation alternations. A CRISPR mutation experiment revealed that the function levels of Kcc4a correspond to the fin and barbel lengths. In addition, kcnk5b knockout in the schleier fish embryos can reduce the adult fin lengths, suggesting that Slc12a7a might function together with Kcnk5, and both might be required for bioelectric regulation in wildtype fish. Interestingly, the same research group also identified slc43a2/lat4a, an L-leucine amino acid transporter that can modify the kcnh2a mutation effect in loft2 mutant fish, resulting in a flying-fish-like phenotype [106]. This lat4a mutant, lat4anr21, is also dominant and exhibits a short-finned phenotype in heterozygotes. The interactions between Lat4a and Kcnh2a in the flying-fish-like zebrafish suggest they are also involved in bioelectric regulation. Along with this short-finned phenotype, two additional mutants were reported. They are the shortfin (sof) mutants (4 alleles: sofb123 (spontaneous), sofj7e1, sofj7e2, sofj7e3 (ENU-induced)) caused by a hypomorphic mutation in the gap junction, Cx43 [109], as well as a fish mutant, mau, caused by a dominant missense mutation in aqp3a (aquaporin 3a) [110]. Like the lat4anr21 mutation, the cx43 mutation in sof also reverted the loft2 long-finned phenotype [111], suggesting that Cx43 is another bioelectric regulator for zebrafish fin size.
Our laboratory recently characterized a dominant long-finned mutant, Dhi2059, which was generated via a large-scale insertional mutagenesis [112]. The kcnj13 gene’s exon 5 was disrupted by a retroviral insertion. Although this exon encodes 5′ UTR (untranslated region), not protein, viral DNA insertion leads to a transient and ectopic expression of kcnj13 in the somites between 15S (15-somite stage) and 48 dpf (days post fertilization) in Dhi2059 fish embryos. Transgenic fish Tg (−5.4k pax3a: kcnj13-IRES-EGFP), in which the kcnj13 gene is under the control of the −5.4k pax3a promoter, can phenocopy the long-fin phenotype. Thus, kcnj13 misregulation resulted in elongated fins in the adult zebrafish, mainly by increasing the length of fin rays [112]. Different from the previously mentioned long-finned mutants (lof, alf, schleier), our results suggest that the adult fin size can be determined at the somite stage in early fish embryos. This indicates that bioelectricity is set up early and could serve as a memory for patterning and size regulation in later ontology (see detailed discussion in the prospective section). In addition, we showed that transient expression of multiple potassium channels (kcnj1b, kcnj10a, kcnk9, human KCNJ13) in zebrafish early embryos (by microinjection) could also cause chimeric long fins in injected adult fish. This result suggests it is not a specific potassium channel, but that bioelectricity is the key to the elongated fin phenotype.
Multiple key points can be obtained by comparing these zebrafish mutants. First, all the mutant genes are involved in ion regulation, which is intrinsically linked to bioelectricity. These ion regulators have their own ion type selecting properties and conductance. It becomes challenging to explain the fin phenotype with a specific channel or ion. Instead, it is more reasonable that electric signaling is the underlying mechanism. Different ion regulators with other properties can be used to construct and modify the bioelectric state of cell groups and tissues. Second, all of these mutations are genetically dominant; most are gain-of-function, ectopically expressed, or neomorphic. Lastly, the specificity of the zebrafish fin-size phenotype may be caused by the spatiotemporal distribution of these ion regulators during embryonic development, as exampled by the Dhi2059 mutant. Taken together, the zebrafish’s adult fin size could be regulated at multiple stages. Although most studies reported altered gene expression in fin anlagen or local fins, our experimental data suggested that somites, the embryonic origin of fin ray progenitor cells, can play a critical patterning role.
Consistent with zebrafish mutants, it is also worth noting that different potassium channels were recently identified in other teleosts through genome association studies. The inwardly rectifying channel gene kcnj15 was mapped to long-finned betta fish [113]. Additionally, the ether-à-go-go (EAG) potassium channel gene, kcnh8, was found to be highly expressed in the male caudal fins in Xiphophorus [114]. Like zebrafish, kcnk5bS was identified as a candidate for long-tailed goldfish [115]. Together with zebrafish mutants, these data suggest that ion-channel-mediated bioelectricity plays an essential role in fin patterning.
Table 2. Zebrafish, published fin-size mutants.
Table 2. Zebrafish, published fin-size mutants.
MutantFinGeneMutation
Nature
Fin Ray Segment LengthFin Ray NumbersDominant or RecessiveSomite or Local FinReferences
lofLongkcnh2aEctopic by cis-regulatory changeNormalIncreasedDominantLocal[105,106]
alfLongkcnk5bGOFIncreased DecreasedDominantLocal[107]
schleierLongslc12a7a/kcc4aLOF or dominant negative?
Dose dependent
NormalIncreasedDominantLocal[108]
Dhi2059Longkcnj13Ectopic by cis-regulatory change, Dose dependentIncreased DecreasedDominantSomite[112]
sofShortcx43Hypomorphic Decreased DecreasedDominantLocal [109]
mauShortaqp3aNeomorphic, Dose dependentNormalDecreasedDominantLocal[110]
nr21Shortslc43a2/lat4aGOFDecreasedNot reportedDominantLocal[111]
Note: GOF: gain-of-function; LOF: loss-of-function.

3.3. Zebrafish Mutants with Adult Pigmentation Pattern Alterations

Zebrafish adults exhibit distinct stereotypical stripe patterns along their bodies, with alternating rows of melanophores (dark pigments) and xanthophores (red-orange pigments) mixed with iridophores (iridescent pigments) [116,117,118]. Local and long-range interactions and communication among these different pigment cells during embryonic and larval stages are essential to forming the stripe patterns [79,115,116]. Among many mutant zebrafish lines with altered pigmentation patterns, several are mutations of ion regulators, suggesting that ion-channel-mediated bioelectric signals play important roles in pigmentation patterning. Two of the fish mutants, albino and golden, resulted from the loss of function of solute carrier genes, slc45a2 and slc24a5, respectively [119,120,121]. The phenotypic results of the two mutants are a complete loss of melanophores and light stripes (melanophores with small and fewer melanin granules), respectively. The two genes are expressed in zebrafish melanophores, and light pigmentation was thought to be mainly caused by reduced melanogenesis due to ion and proton alteration in the melanophores [120,121]. The transparent (tra) fish possess fewer iridophores, melanophores, and dark spots, instead of stripes, in adults. This tra is a loss-of-function mutation of the mpv17 gene, which encodes a non-selective channel that modulates mitochondria membrane potential [122,123]. Although the loss of Mpv17 was found to cause a reduction in the number of mitochondria and reduced pyrimidine synthesis [123], the bioelectricity of iridophores might also contribute to patterning defects.
In addition to chromophore defects, zebrafish stripe patterns were found to be altered in additional mutants. The leopard (leot1) mutation, also known as tup, is a spontaneous recessive mutation causing spots in the adult Tüpfel fish line. This mutation is caused by the cx41.8 (connexin 41.8) gene, which encodes Gja5b in zebrafish [124]. Similarly, luchs (luctXA9) is a mutation of the cx39.4 (connexin 39.4) gene, which encodes Gja4 [124]. Both cx41.8 and cx39.4 are required for melanophore and xanthophore development. Both mutants show aggregated dark spot patterns instead of stripes. Interestingly, it was shown that these two connexins could form heteromeric, in addition to homomeric, gap junctions, which are essential for melanophore and xanthophore cellular communication [124,125]. Recently, another mutant zebrafish, schleier, was reported to be caused by hypomorphic function of another solute carrier, slc12a7a/kcc4a [108]. The homozygous mutant fish show broken stripes in the ventral body flank and anal and caudal fins. Gap junctions usually conduct small molecules and ions between neighboring cells. Thus, they can modulate molecular and electrical coupling among the adjacent cells [81,82], and over longer distances [79,80]. Additionally, the obelix(obe)/jaguar(jag) mutants, which are caused by a kcnj13 loss of function, have fewer stripes compared to wildtype fish [126]. Kcnj13 is an inwardly rectifying potassium channel that regulates cell excitability and membrane potential. Based on the less severe pigmentation phenotype of the kcnj13 null mutants (kcnj13pu107, kcnj13pu109) our lab generated, the original alleles (jagb230, obetc271d, and obetd15) are most likely dominant negative [112,126]. More recently, kcnj13 expression was found to underlie the pattern diversification among Danio species via the kcnj13 regulatory changes [127]. This potassium channel gene is expressed in melanophores during development, suggesting that it may regulate melanophore bioelectric properties. Indeed, cellular electrical communication was partially disrupted in this mutant. The dissociated melanophores of jag are more depolarized when measured with a voltage-sensitive dye, DiBAC4(3), than the melanophores from wildtype fish. Wildtype melanophores are transiently depolarized when contacted by the dendrites of a xanthophore, and then moved away from the xanthophore. In contrast, jagb230 melanophores lost contact-dependent depolarizations and repulsive migration behavior [128].
Three additional zebrafish mutants could also be related to bioelectric regulation, though the related genes are not direct ion regulators. Spermidine is an endogenous polyamine that can regulate ion channels and connexins [129,130]. The idefix (idet26743) fish is a loss-of-function mutant of the srm (spermidine synthase) gene [131]. Homozygous idet26743 mutants have fewer narrowed and often interrupted dark stripes in the trunk and fewer strips in the fins. This ide mutation can further reduce melanophores when crossed with leot1, luctXA9, and obe271d mutants, suggesting that spermidine may modulate connexin and potassium channel functions. Moreover, ectopic expression of spermidine/spermine N1-acetyltransferase (Ssat), a polyamine metabolic enzyme in melanophore, caused broken stripes and a loss of melanophores in the leot1/t1 background, also supporting this idea [132]. Another zebrafish mutant, schachbrett (sbrtnh009b), is caused by a loss of function mutation of tight junction protein 1a (Tjp1a), which is expressed in iridophore [133]. Like idet1, the sbrtnh009b mutant exhibits more substantial pigment patterning defects in luct32241 and leot1 background, indicating Tjp1a may interact with connexins. Thus, Tjp1a may indirectly affect the bioelectricity of chromatophores. The third zebrafish mutant, mau, also possesses spotted pigments. The underlying gene of the mau mutation is aqp3a, which is mainly expressed in skin and muscle, but not in chromatophores [110]. Transplantation of aqp3atVE1/+ blastomere cells into wildtype and Aqp3aR220Q in a transgenic experiment revealed that Aqp3a might indirectly influence chromatophores for pigment patterning. Aqp3a is a transporter of non-polar solutes such as glycerol, peroxide, and urea, excluding ions [134]. Thus, Aqp3a can modulate the ion concentrations related to cellular bioelectricity.

4. Genetically Encoded Tools That Can Be Used for Studying Developmental Bioelectricity

Functional studies of the bioelectric mechanisms of embryonic developmental processes require suitable tools with which to measure endogenous bioelectricity in a real-time and non-invasive manner and manipulate cell and tissue bioelectricity without compromising whole embryo tissue integrity. With recent significant advances in neuroscience, various genetically encoded tools were developed to meet these purposes. Genetically encoded indicators, or biosensors, can allow us to measure cellular membrane potential, ion concentration, and even metabolites via fluorescence [135,136]. Additionally, chemogenetic and optogenetic tools allow us to manipulate cellular bioelectricity, such as membrane potential, in a precise manner [137,138,139,140,141,142,143]. Although initially developed for studying neurons, these tools can also be utilized in other research contexts, such as for studying bioelectricity in embryonic development.

4.1. Measuring Cellular Bioelectricity: Genetically Encoded Voltage Indicators

Cellular electric neural activity can be accurately measured using traditional electrode measurements, such as the patch clamp method. This method is highly accurate, but is generally limited to single-cell recordings and invasive to cells [144,145,146]. Calcium has also been widely used to reflect neuronal electric activities. Genetically encoded calcium indicators, GECIs, have been widely implemented into the zebrafish model for neural studies [147,148,149], cell migration [150,151], embryogenesis [152,153], insulin secretion from pancreatic beta cells [154], and many other biological processes [155,156,157,158]. Although calcium signals mimic electric signals, they are still different due to their additional function as a secondary messenger in various cell types. Indeed, a difference was reported in calcium and voltage signals [159,160]. Genetically encoded voltage indicators (GEVIs) were invented to directly measure neurons’ electrical activity, complementary to patch clamp electrophysiology. These non-invasive, endogenous fluorescent biosensors can function over multiple cells and tissues to provide a collective understanding of real-time bioelectric activities versus single cells. These are also more advantageous over previously developed electrochemical dyes due to their increased speed, genetic specificity, higher sensitivity, and lack of toxic effects [161]. The fastest GEVIs have reported rates up to 1 ms [135]. Another advantage of GEVIs is the ability to provide results over extended periods. While these sensors offer several advantages, they do have some drawbacks, such as genetic modification and the high-end fluorescent microscopes required, variable dynamic ranges, and signal-to-noise ratios [135]. However, with the advance of technical developments, these shortcomings are being overcome, and GEVI applications are expanding beyond neuroscience into many fields, such as developmental biology.
Thus far, numerous advancements and variations of GEVIs have been developed (Table 3). These GEVIs usually fall into one of three categories (Figure 2A) [135,162,163]: (1). GEVIs based on a voltage-sensitive domain (VSD) within the cell membrane, usually from the tunicate (Ciona intestinalis) voltage-sensitive phosphatase, PTPE [164,165]. The VSD can be linked with either a single fluorescent protein (FP), dual FPs for FRET (Forester resonance energy transfer) signaling, or even bioluminescence. (2). Opsin-based GEVIs, with and without additionally combined FPs to improve brightness. (3). There is a group of hybrid GEVIs that combine these different components with the addition of brighter and more photostable synthetic dyes [135,162,163]. Each GEVI has its unique properties and application niche. Many of these GEVIs have also been examined and utilized in zebrafish research (Table 3).
One commonly used GEVI is ASAP (accelerated sensor of action potentials) based on VSD design. A circular permutated GFP is inserted int the middle of S3–S4 loop of the VSD. Thus, when the VSD protein confirmation is altered by Vm, the intensity of GPF fluorescence will change correspondingly (Figure 2A). When the cell membrane is hyperpolarized, the ASAP1 fluorescence signal is brighter. This ASAP1 was successful, and neuron bioelectricity has been well-documented in many model organisms, including zebrafish. A few updated versions have also been developed to improve its speed, signal-to-noise ratio, and sensitivity [166,167,168,169]. Our lab has generated a ubiquitous transgenic reporter zebrafish line Tg(ubi: ASAP1) [170,171]. With this ASAP1 transgenic fish line, real-time endogenous cellular bioelectric activities can be visualized in fish embryos, larvae, adults, and even tumor tissues [170]. Our results are consistent with an independent report on Tg(UAS: ASAP1), a binary transgenic fish line for tracking larval fish neuronal circuitry within cerebellum, optic tectum and spinal cord [172,173]. In addition, we made new observations in early fish embryos. We found that a transient local membrane depolarization occurs before cleavage furrow formation during zebrafish embryo cleavage stages (1–64 cells). This phenomenon is consistent with calcium signaling measured by GCaMP6s [153]. These Vm changes are not static, but dynamic during the cell division period. Moreover, these Vm dynamic changes are not perfectly synchronized among early cells. These results suggest a biological function of Vm in cell division. Membrane potential changes have been shown to influence the organization of phospholipids. These are known as critical components of the cleavage furrow and cytokinesis [36,174,175]. Once zebrafish embryos enter the blastula stage, the bioelectric signals become whole-cell transient hyperpolarizations, mainly found in the rapidly dividing superficial layers of the blastula (EVL) and yolk syncytial layer (YSL). During gastrulation, Vm transients continued in the EVL and YSL, and started to occur in the deeper cells. Moreover, we noticed differential Vm among different embryonic tissues and somite-specific hyperpolarization events during the zebrafish embryonic segmentation period. These results demonstrated that the ASAP family and potentially other GEVIs could be readily used for measuring embryonic bioelectricity. We expect more bioelectric biology to be revealed by organ- and/or tissue-specific zebrafish transgenic fish lines. For example, different cell types in the zebrafish fins, pigment cells, and the other cell types in the skin can be characterized for their physiological bioelectric properties (for details, see the prospective section).
It is worth noting that GEVIs are not limited to zebrafish. They have also been applied to other organisms. For example, multiple studies have shown the utility of genetically encoded indicators in fruit flies, but have, thus far, only been focused on neuronal-related studies [167,169,176,177,178]. In mice, fewer research studies have utilized GEVIs in vivo, and most of these studies focused on neurological research [178,179,180,181,182]. In addition, Xenopus oocytes were used to characterize Arclight, but did not address any developmental biology [183]. Nevertheless, their results showed that these sensors could be employed to characterize bioelectricity in Xenopus if needed.
Table 3. List of published genetically encoded voltage reporters.
Table 3. List of published genetically encoded voltage reporters.
GEVIsFluorescence IndicationFluorophoreTested in ZebrafishReferences
VSD-based
ASAP1–3Hyperpolarize—brighterGFPWhole fish embryos and larva. Adult malignant nerve sheath tumors, larval fish cerebellum, spinal cord.[166,167,168,169,170,171,172,173]
ASAP4Depolarize—brighterGFP [184,185]
MarinaDepolarize—brighterGFP [186]
FlicR1Depolarize—brighterRFP [187]
ArclightHyperpolarize—brighterGFP [188,189]
BongwooriHyperpolarize—brighterGFPLarval olfactory bulb[190,191]
AahnHyperpolarize—brighter (external)GFP [192]
VSFP xDepolarize—FRET increaseMultipleLarval zebrafish heart[193,194,195,196,197,198,199,200]
MermaidDepolarize—FRET increaseMultiple [201]
NabiDepolarize—FRET increaseUGK/mKO [202]
JEDI-2PHyperpolarize—brighterGFP [178]
Opsin-based
ArchDepolarize—brighterGFP [203]
QuasAr xHyperpolarize—brighterMultipleLarval zebrafish heart[204,205,206,207,208]
Archon1Depolarize—brighterGFP/RFPBrain and spinal V3 interneurons[209,210]
Ace xHyperpolarize—brighterGreen/RFP [211,212]
Ace-mNeon2Hyperpolarize—brighterGFP [182]
VARNAMHyperpolarize—brighterRFP [213]
VARNAM2Hyperpolarize—brighterRFP [182]
pAceDepolarize—brighterGFP [182]
pAceRDepolarize—brighterRFP [182]
Dye- or bioluminescence-based
VoltronHyperpolarize—brighterMultiple dyesLarval brain[214]
Voltron2Hyperpolarize—brighterMultiple dyesLarval olfactory sensory neurons[215]
PositronDepolarize—brighterMultiple dyesLarval zebrafish brain[216]
hVOSDepolarize—brighterGreen dye [217]
Voltage spyDepolarize—brighterGreen dye [218]
LOTUSDepolarize—FRET increaseBlue/green bioluminescence [219]
AMBERDepolarize—voltage-gated luciferase increaseBlue/green bioluminescence [220]

4.2. Manipulate Cellular Bioelectricity: Optogenetic and Chemogenetic Tools

Another requirement to elucidate the bioelectric signaling mystery is the direct and specific perturbation of the normal electrical state of cells and tissues. As this was a major task for neuroscience, optogenetic and chemogenetic tools were already developed as experimental approaches (Figure 2B and Table 4). These tools have, thus far, demonstrated the capability to alter cell-specific electrical states of neurons to hyperpolarization and depolarization, allowing a precise level of control in various organisms [137,138,139,221,222,223].
Optogenetics: Optogenetics modulates bioelectricity through microbial (type I) opsins, which are light-sensitive ion pumps and ion channels found in prokaryotic and eukaryotic microbial organisms [224]. These type I opsins can conduct cations or anions under the control of different wavelengths of light [225,226,227]. When exposed to specific wavelengths of light on expressing cells, channels open to allow specific ions, such as H+, Na+, Ca2+, or Cl, into cells, resulting in increased or decreased Vm. The use of optogenetics in zebrafish has been primarily targeted in neuroscience studies. These have been used to modify swimming behavior [228] and locomotion behavior [229], perturb hair cell sensory receptors [230], axon guidance control [231], and alter olfactory responses [232]. Optogenetic tools have also been used for other zebrafish research fields, such as heart physiology [233,234], and melanophore patterning [235]. In the zebrafish melanocyte study, ChR2 was expressed in the melanophores of zebrafish that were then placed in tanks exposed to blue light to stimulate depolarization [235]. As a result, these transgenic fish began to lose the boundaries of their standard stripe patterns [235]. Interestingly, this was partially reversed after allowing the depolarized cells to return to their average membrane potential, suggesting that endogenous bioelectric signals are essential for maintaining pigment homeostasis. This study also provided direct evidence of bioelectric signals in zebrafish pigment patterning. Recently, a set of optogenetic transgenic zebrafish lines have been created under the control of the UAS promoter [141]. This will accelerate bioelectric research in zebrafish. Moreover, with the great success of light-sensitive rhodopsin, new optogenetic tools have been invented with which to control gene expression, protein localization, and activity, using a new set of light-sensitive proteins such as phytochromes, blue light using flavin (BLUF) domain photoactive proteins, cryptochromes (e.g., CRY2-CIB1), and light oxygen voltage (LOV) domain proteins. Their applications to developmental biology and zebrafish have already been reviewed [236,237]. These new optogenetic tools are also utilized for investigating zebrafish bioelectricity.
Chemogenetics: Chemogenetics is a genetic approach to perturb cellular electrical activity using synthetic molecules through either mutated G-protein-coupled receptors (GPCRs) or ligand-gated ion channels that no longer function normally, but only in the presence of inert molecules [222,223].
DREADDs (Designer receptors exclusively activated by designer drugs) are one of the mainstream chemogenetic tools that are commonly used in neuroscience, including in the study of behavior, circuits, and diseases [222,238,239,240]. DREADDs are designed based on mutated muscarinic and opioid receptors. Four types (hM3DGq, hM4DGi, hM3DGs, and KORD) alter cellular Vm through downstream signaling changes, such as the arrestin pathway, intracellular Ca2+, and cAMPs that indirectly modulate ion channels. The original agonist is clozapine-N-oxide (CNO), a derived metabolite of clozapine, which is used as an antipsychotic. Thereafter, it was found that CNO can be converted into clozapine and cause psychoactive side effects in murine models [241]. Subsequently, more potent and specific agonists were invented, including JHU37152, JHU37160, and deschloroclozapine (DCZ) [242,243]. In addition to the choice of agonist, the diverse signaling pathways downstream of receptors make electricity manipulation less straightforward. Furthermore, the biological reactions could be variable in different cell types. Recent progress on DREADD structure activation is helpful for us to understand the mechanisms of their activation [244]. Still, careful experimental design was proposed to overcome the two potential issues in animal models [245]. Despite these weaknesses, the DREADD tools have found their way into various animal models, including flies, mice, rats, and primates [246]. In addition, DREADDs have also been extended to other research fields, including diabetes and endocrinology [247,248]. However, they have not been implemented in zebrafish yet. One study tried to utilize DREADD in zebrafish by microinjections, but failed in the endeavor [249]. Instead, they demonstrated that transient receptor potential (TRP) channels worked in the zebrafish embryos, and successfully manipulated Rohon–Beard and trigeminal sensory neurons using islet-1 enhancer-driven TRP channels [249]. TRPV1 was activated by capsaicin, TRPM8 was activated by adding menthol, while TRPA1 activity required temperatures above 28 °C. Activation of TRPs induced dose-dependent locomotion and ablation, and altered wake-sleep behaviors [249]. In addition, the TRPV1-based approach was verified in another zebrafish study for modulating calcium flux in neutrophil [150]. Our laboratory has applied one of the DREADD, hM4DGi, to zebrafish embryos and larvae, and was able to change melanophore pigment cell dispersion [250]. Although the voltage reporter efficiency still needs to be improved, our results suggest that DREADD can be applied to zebrafish bioelectricity research.
PSAMs (pharmacologically selective actuator modules) are another set of chemogenetic tools. PSAMs share a similar key-and-lock concept, utilizing artificial inert molecules as agonists. For the actuator, instead of using mutated GPCRs as a lock, PSAMs use ligand-gated ion channels, such as nicotinic receptors (nAChR), serotonin receptor 3 (5HT3), GABA receptors, and the glycine receptor (GlyR). Each PSAM has a ligand binding domain (LBD) and a channel. These are mutated ligand-gated ion channels that can only be activated by PSEMs (pharmacologically selective effector molecules) [251,252]. Recently, a ligand-binding domain was genetically engineered, and more potent agonists were identified. Thus, this ultrapotent system is helpful for research and suitable for therapeutic applications, as exampled in mice and monkeys [251]. The first generation PSAM-GlyR was expressed in zebrafish horizontal cells (HCs), which connect rod and cone photoreceptors via synapses [253]. Disrupting Vm of HCs resulted in altered light response and lateral inhibition in retinal ganglion cells. This study illustrated that the ultrapotent PSAM-PSEM system could be extended for zebrafish bioelectric research.
In addition to the chemogenetic and optogenetic tools mentioned above, direct genetic modification, i.e., adding or deleting an ion channel regulator, is also achievable with the established tol2-transposon transgenic system and CRISPR technology [254]. This has already been demonstrated, such as in the transgenic Tg(−5.4k-pax3a: kcnj13-IRES-EGFP), where transient ectopic expression of kcnj13 in zebrafish dermomyotome causes a long-finned phenotype in adults [112]. Nevertheless, this approach depends on already-known ion channel regulators and an available tissue-specific promoter. In addition, this genetic modification cannot be turned on and off, as with chemogenetic and optogenetic tools. Nevertheless, these tractable genetic tools are critical for implanting GEVIs, chemogenetics, and optogenetics into zebrafish.
Table 4. Common optogenetic and chemogenetic tools.
Table 4. Common optogenetic and chemogenetic tools.
Optogenetic ToolsChemogenetic Tools
NameActivation MethodActivation ResultTested in ZebrafishReferencesNameActivation MethodActivation ResultTested in ZebrafishReferences
ChR2Blue light (470 nm)DepolarizationMelanophores, hair-cells, neurons [141,230,235,255]hM4DGiDREADD agonistsHyperpolarizationMelanophore[222,250]
eNpHR3.0Yellow light (590 nm)HyperpolarizationNeurons[141,256]hM3DGqDREADD agonistsDepolarization [222]
CoChRBlue light (470 nm)DepolarizationNeurons[141,257]hM3DGsDREADD agonistsDepolarization [222]
GtACR1Green light (515 nm)HyperpolarizationNeurons, heart[141,258,259,260]KORDDREADD agonistsHyperpolarization [222]
GtACR2Blue light (470 nm)HyperpolarizationNeurons, heart [141,259,260,261]PSAM-5HT3-HCPSEM ligandsDepolarizationHorizontal cells[251]
BLINK2Blue light (455 nm)HyperpolarizationHair cells, lateral line neuromasts, neurons [262]PSAM-5HT3-LCPSEM ligandsDepolarizationHorizontal cells[251]
CheRiffUV light (460 nm)DepolarizationNeurons[141,204]PSAM-GlyRPSEM ligandsHyperpolarizationHorizontal cells[251,253]
ChronosYellow light (500 nm)DepolarizationNeurons[141,263]TRPV1CapsaicinDepolarizationNeurons, neutrophils[150,249]
eArchT3.0Yellow (570 nm)HyperpolarizationNeurons[141,264]TRPM8MentholDepolarizationNeurons[249]
ChrimsonRRed light (590 nm)DepolarizationNeurons[141,265]TRPA1>28 °CDepolarizationNeurons[249]
GluCl v2.0Ivermectinhyperpolarization [266]

5. Prospects and Opportunities: Future Directions for Developmental Bioelectricity

The above-mentioned zebrafish fin and pigment genetic mutations are indirect evidence of bioelectricity in developmental patterning. Direct bioelectricity research in zebrafish is only possible now because of the recent availabilities of new voltage biosensors and manipulators. Although, here, we use zebrafish fin size and pigment cell patterns as examples, many other research directions can be pursued in this field. Below, we propose four major perspectives.

5.1. Systematic Zebrafish Embryo Bioelectricity Characterization

Though electrical signaling in neuronal tissues has been widely accepted and extensively investigated, other embryonic tissues remain completely unexplored. Characterizing non-neuronal tissues/cellular bioelectric signaling during embryogenesis is essentially the first step for deciphering the roles of bioelectricity. The in vivo real-time systematic characterization of vertebrate embryos has only just begun. Our Tg(ubi:ASAP1) fish line provided the first example of endogenous hyperpolarization signals of embryonic tissues [171]. More tissue-specific fish lines can be created with newly developed, more sensitive GEVIs, such as JEDI-2P, voltron2, Ace-mNeon2, and VARNAM2 using Tol2 transgenesis and CRISPR knock-in [178,182,215]. For example, in order to investigate somite cell contribution to the fins in our Dhi2059 mutant, somite compartments (dermatome, sclerotome, and syndetome) can be labeled with ASAP1 and other GEVIs to investigate the bioelectricity of these embryonic tissues in the future. On the other hand, faster and more sensitive imaging technologies, such as light-sheet fluorescence microscopes, have made this task more achievable [171,267,268]. It is possible that not only cellular Vm, but also its fluctuation amplitude, frequency, and rhythms, can serve as cell signals. Such tissue-specific, cell-type-specific, or subcellular bioelectric imaging in zebrafish embryos will reveal unprecedented insight into the functions of bioelectricity during embryonic development. Moreover, this information will be helpful in testing the theoretical concept of “the bioelectric code” [269,270,271]. In addition to GEVIs, biosensors for ions, such as the potassium sensor GINKO2 [272] and the chloride sensor ClopHensor [273], can also add another layer of information on bioelectricity.

5.2. Identifying Bioelectricity Contributing Genes and Redundancy of Ion Regulators

The cellular bioelectricity of a given cell type is composed of many ion regulators, as discussed above. However, major contributors of each cell type at a given embryonic stage also remain uncharacterized. Technically, the major challenge is ion regulator redundancy. Forward genetics starts with mutants created by random mutagenesis, and then addresses which gene is responsible for the mutant phenotype. This approach is powerful for identifying critical genes given a phenotype, especially embryonic development, in multiple model organisms, including flies, worms, mice, and zebrafish [94,274,275,276]. However, this approach might miss the underlying genes when genetic or biochemical redundancy exists. It is already known that multiple ion channels, connexins, pumps, and solute carriers can contribute to the overall cellular bioelectronic properties, though some are more prominent than others, given a cell type. There are 817 channel/transporter proteins known in the human genome in the cell membrane [277]. Many transporters underline many cellular functions, but also create redundancy that could make cellular bioelectric homeostasis very robust (Figure 3) [278]. Thus, it is unsurprising that only a limited number of zebrafish mutants were identified with altered fin and pigment patterns. Thus far, all the known fin-size mutations are genetically dominant. Most of them are either ectopically expressed (kcnj13, kcnh2a) or gain-of-function mutations (kcnk5b, aqp3a, and lat4a) (Table 2). This ismost likely because the loss of one ion regulator is generally insufficient to cause overall cellular bioelectric change. However, overexpression or gained function of ion regulators could drive the cell’s bioelectric property out of its physiological range (Figure 3). Thus, this type of mutant displays a developmental patterning phenotype. Dominant negative mutations of ion regulators may also function by interrupting structurally similar proteins in the same family. For example, the kcc4a in the schleier mutation could be interpreted as a dominant negative form, since the null mutant has no fin phenotype [108]. This redundancy not only leads to no phenotype, but also makes the experimental interpretation difficult. What is the solution to overcome the redundancy? With single-cell sequencing, it is feasible now to profile all the enriched ion regulators given a cell type [279,280]. For example, abundant ion regulators in different cell types within zebrafish somites and fins can be identified using this technique. Alternatively, whole mount in situ hybridization can be performed systematically, to examine their expression during zebrafish embryogenesis, as was performed in the case of the potassium channel gene subfamilies [281,282]. Once their gene expression is known, cell- and/or tissue-specific multiplexing gene knockout or knockdown by CRISPR can be used to examine certain ion regulators’ function in developmental patterning [283,284,285,286,287]. Moreover, chemogenetic and optogenetic tools are also expected to be effective to override endogenous ion regulators in a treated time window (Figure 3).

5.3. Developmental Patterning by Bioelectric Memory

Another fundamental question about bioelectricity is how it works during embryogenesis. From the current data of the zebrafish pigment mutants, cell–cell interactions are critical for adult pigment patterning. Moreover, the interaction between the pigment cells and other skin cells could also be important, as suggested by the transplant experiment of the mau fish [110]. One key phenomenon of bioelectric patterning we have learned from the Dhi2059 long-finned mutant is that the adult fin patterning can be determined much earlier, even back to the 1–2 dpf fish embryo stages [112]. The zebrafish larva fin buds have not yet developed at this embryonic stage. Very likely, the transient alteration of bioelectric properties of the two waves of fin progenitor cells, which migrate from somites into the fin buds [288,289], is enough to change adult zebrafish fin size. This memory of bioelectric property change may influence the differentiated cell interaction later in the fin anlagens. This bioelectric memory concept has been proposed and validated in the head–tail body axis determination in flatworms by the Levin research group [290]. Depolarizing edema cells during the first three hours after amputation is enough to cause a double-headed phenotype in flatworms, indicating that bioelectric memory is critical for patterning [291]. Thus, it is also reasonable that the bioelectric memory could be affected in other reported long-finned mutants [105,107,108]. Based on this, we have proposed a two-stage model for fin-size regulation [112]: the bioelectric memory may be formed at the somite stage, before the fin progenitor cells migrate to the fin buds. Furthermore, this memory can guide the local cell interactions and eventually determine the fin shape and size. However, the bioelectric memory can also make the developmental patterning mechanism more elusive. Generally, there will be a time lag for the phenotype development after bioelectric perturbation. Moreover, the bioelectric memory formation might occur within a short time window. Therefore, careful experimental design, including cell lineage tracking, bioelectricity measurement, and perturbation, is essential to decipher this intriguing mechanism.

5.4. Biological Pathways Downstream of Bioelectricity in Different Systems

Discovering unknown downstream signaling pathways of Vm on different functions could help explain all the diverse functions of bioelectricity. There is still a long way before we know how this biophysical cue is integrated into current biochemistry theory. As neural action potentials can deliver a signal to a long-range destination along the axon and relay by neurotransmitters, the non-excitatory embryonic tissues may use a similar mechanism in an atypical way for guiding cell–cell interactions. Instead, the embryonic cells may form weak bioelectrical networks [8]. Different cells and tissues may dominantly utilize specific pathways.
The morphogen protein gradient is one of the most influential developmental patterning principles with solid experimental support from many organisms, including zebrafish [292,293]. Relationships between bioelectricity and morphogen proteins, and their downstream transcription factors, are particularly interesting (Figure 3). This information will help us better understand how bioelectricity works and its interaction or cross-talks with current already-known morphogen proteins. No clear experimental evidence was reported in zebrafish yet, but multiple morphogen-signaling pathways were directly or indirectly linked with bioelectricity in other organisms. For example, cell membrane resting potential can alter a frog’s brain development through Notch signaling [294]. BMP signaling also mediates morphological changes of Kcnj2/Kir2.1 gene mutations in both flies and mice [295,296,297]. However, the ion channel and WNT signaling relationship are less clear in developmental biology, and there is limited evidence from pathological conditions [298]. The most apparent case is bioelectricity and the hedgehog-signaling pathway. Two transient receptor potential (TRP) channels, PKD1L1 and PKD2L1, modulate ciliary calcium concentration, and the loss of these two channels leads to increased Gli1 activity and subsequent hedgehog signaling [299,300]. Additionally, direct evidence was reported that optogenetic depolarization was found to promote smoothened membrane localization and increase hedgehog signaling, which also promotes cellular depolarization in the fly wing disc [301]. Furthermore, two critical components of this pathway, DISP1 and PTCH1, function as cation-powered transporters. DISP1 utilizes the transmembrane sodium ion gradient to release cholesterylated SHH from HEK293 cells. In comparison, the PTCH1 receptor behaves as a K+-powered cholesterol transporter, which employs a transmembrane potassium ion gradient to antagonize SMO with cholesterol in NIH-3T3 cells [302]. Another report found the PTCH1 inhibits SMO and depends on extracellular sodium ion concentration [303]. Thus, bioelectricity may modulate multiple steps of hedgehog signaling from SHH secretion (establishment of morphogen gradients) to SHH reception (interpretation of morphogen), indicating bioelectricity patterning may be mediated by morphogen-signaling pathways, at least partially.

6. Conclusions

Bioelectricity has emerged as a new player in developmental patterning and organ size control. Here, we focused on the zebrafish model system and systematically reviewed genetic evidence of bioelectricity from zebrafish mutants. Additionally, we briefly summarized the newly developed genetically encoded voltage indicators and cellular voltage manipulators (optogenetics and chemogenetics) and their potential to be used for zebrafish bioelectricity research. Finally, we discussed future directions and opportunities for bioelectricity research in developmental patterning.

Author Contributions

Conceptualization, G.Z.; writing—original draft preparation, M.R.S. and G.Z.; writing—review and editing, M.R.S. and G.Z. All authors have read and agreed to the published version of the manuscript.

Funding

This research was supported by the National Institute of General Medical Sciences of the National Institutes of Health (2R35GM124913) to G.Z. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agents.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

We thank Zhang lab members Sung Jun Park, Ziyu Dong, and Dingxun Wang for proofreading this manuscript.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Lander, A.D. Pattern, growth, and control. Cell 2011, 144, 955–969. [Google Scholar] [CrossRef] [Green Version]
  2. Salazar-Ciudad, I.; Jernvall, J.; Newman, S.A. Mechanisms of pattern formation in development and evolution. Development 2003, 130, 2027–2037. [Google Scholar] [CrossRef] [Green Version]
  3. Takahashi, Y.; Osumi, N.; Patel, N.H. Body patterning. Proc. Natl. Acad. Sci. USA 2001, 98, 12338–12339. [Google Scholar] [CrossRef] [Green Version]
  4. Wolpert, L. Positional information and the spatial pattern of cellular differentiation. J. Theor. Biol. 1969, 25, 1–47. [Google Scholar] [CrossRef]
  5. Peter, I.S.; Davidson, E.H. Assessing regulatory information in developmental gene regulatory networks. Proc. Natl. Acad. Sci. USA 2017, 114, 5862–5869. [Google Scholar] [CrossRef] [Green Version]
  6. Negrete, J., Jr.; Oates, A.C. Towards a physical understanding of developmental patterning. Nat. Rev. Genet. 2021, 22, 518–531. [Google Scholar] [CrossRef]
  7. Levin, M. Molecular bioelectricity: How endogenous voltage potentials control cell behavior and instruct pattern regulation in vivo. Mol. Biol. Cell 2014, 25, 3835–3850. [Google Scholar] [CrossRef]
  8. Levin, M. Bioelectric signaling: Reprogrammable circuits underlying embryogenesis, regeneration, and cancer. Cell 2021, 184, 1971–1989. [Google Scholar] [CrossRef]
  9. Chang, F.; Minc, N. Electrochemical control of cell and tissue polarity. Annu. Rev. Cell Dev. Biol. 2014, 30, 317–336. [Google Scholar] [CrossRef]
  10. Levin, M.; Pezzulo, G.; Finkelstein, J.M. Endogenous Bioelectric Signaling Networks: Exploiting Voltage Gradients for Control of Growth and Form. Annu. Rev. Biomed. Eng. 2017, 19, 353–387. [Google Scholar] [CrossRef]
  11. Mathews, J.; Levin, M. The body electric 2.0: Recent advances in developmental bioelectricity for regenerative and synthetic bioengineering. Curr. Opin. Biotechnol. 2018, 52, 134–144. [Google Scholar] [CrossRef]
  12. Levin, M. Molecular bioelectricity in developmental biology: New tools and recent discoveries: Control of cell behavior and pattern formation by transmembrane potential gradients. Bioessays 2012, 34, 205–217. [Google Scholar] [CrossRef] [Green Version]
  13. Kulbacka, J.; Choromanska, A.; Rossowska, J.; Wezgowiec, J.; Saczko, J.; Rols, M.P. Cell Membrane Transport Mechanisms: Ion Channels and Electrical Properties of Cell Membranes. Adv. Anat. Embryol. Cell Biol. 2017, 227, 39–58. [Google Scholar] [CrossRef]
  14. Catterall, W.A.; Wisedchaisri, G.; Zheng, N. The chemical basis for electrical signaling. Nat. Chem. Biol. 2017, 13, 455–463. [Google Scholar] [CrossRef] [Green Version]
  15. Stratford, J.P.; Edwards, C.L.A.; Ghanshyam, M.J.; Malyshev, D.; Delise, M.A.; Hayashi, Y.; Asally, M. Electrically induced bacterial membrane-potential dynamics correspond to cellular proliferation capacity. Proc. Natl. Acad. Sci. USA 2019, 116, 9552–9557. [Google Scholar] [CrossRef] [Green Version]
  16. Chimerel, C.; Field, C.M.; Pinero-Fernandez, S.; Keyser, U.F.; Summers, D.K. Indole prevents Escherichia coli cell division by modulating membrane potential. Biochim. Biophys. Acta 2012, 1818, 1590–1594. [Google Scholar] [CrossRef] [Green Version]
  17. Wayne, R. The excitability of plant cells: With a special emphasis on characean internodal cells. Bot. Rev. 1994, 60, 265–367. [Google Scholar] [CrossRef]
  18. Martinac, B.; Saimi, Y.; Kung, C. Ion channels in microbes. Physiol. Rev. 2008, 88, 1449–1490. [Google Scholar] [CrossRef]
  19. Adamatzky, A. Language of fungi derived from their electrical spiking activity. R. Soc. Open Sci. 2022, 9, 211926. [Google Scholar] [CrossRef]
  20. Dehshibi, M.M.; Adamatzky, A. Electrical activity of fungi: Spikes detection and complexity analysis. Biosystems 2021, 203, 104373. [Google Scholar] [CrossRef]
  21. Babikova, Z.; Gilbert, L.; Bruce, T.J.A.; Birkett, M.; Caulfield, J.C.; Woodcock, C.; Pickett, J.A.; Johnson, D. Underground signals carried through common mycelial networks warn neighbouring plants of aphid attack. Ecol. Lett. 2013, 16, 835–843. [Google Scholar] [CrossRef] [PubMed]
  22. Volkov, A.G.; Shtessel, Y.B. Underground electrotonic signal transmission between plants. Commun. Integr. Biol. 2020, 13, 54–58. [Google Scholar] [CrossRef]
  23. Strahl, H.; Hamoen, L.W. Membrane potential is important for bacterial cell division. Proc. Natl. Acad. Sci. USA 2010, 107, 12281–12286. [Google Scholar] [CrossRef] [Green Version]
  24. Eckert, D.; Schulze, T.; Stahl, J.; Rauh, O.; Van Etten, J.L.; Hertel, B.; Schroeder, I.; Moroni, A.; Thiel, G. A small viral potassium ion channel with an inherent inward rectification. Channels 2019, 13, 124–135. [Google Scholar] [CrossRef] [Green Version]
  25. Abdul Kadir, L.; Stacey, M.; Barrett-Jolley, R. Emerging Roles of the Membrane Potential: Action beyond the Action Potential. Front. Physiol. 2018, 9, 1661. [Google Scholar] [CrossRef] [Green Version]
  26. Benarroch, J.M.; Asally, M. The Microbiologist’s Guide to Membrane Potential Dynamics. Trends Microbiol. 2020, 28, 304–314. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Schuetze, S.M. The Discovery of the Action-Potential. Trends Neurosci. 1983, 6, 164–168. [Google Scholar] [CrossRef]
  28. Carmeliet, E. From Bernstein’s rheotome to Neher-Sakmann’s patch electrode. The action potential. Physiol. Rep. 2019, 7, e13861. [Google Scholar] [CrossRef]
  29. Kamada, T. Some Observations on Potential Differences across the Ectoplasm Membrane of Paramecium. J. Exp. Biol. 1934, 11, 94–102. [Google Scholar] [CrossRef]
  30. Hodgkin, A.L.; Katz, B. The effect of sodium ions on the electrical activity of giant axon of the squid. J. Physiol. 1949, 108, 37–77. [Google Scholar] [CrossRef]
  31. Schwiening, C.J. A brief historical perspective: Hodgkin and Huxley. J. Physiol. 2012, 590, 2571–2575. [Google Scholar] [CrossRef]
  32. Hodgkin, A.L.; Huxley, A.F. A quantitative description of membrane current and its application to conduction and excitation in nerve. J. Physiol. 1952, 117, 500–544. [Google Scholar] [CrossRef]
  33. Maqoud, F.; Curci, A.; Scala, R.; Pannunzio, A.; Campanella, F.; Coluccia, M.; Passantino, G.; Zizzo, N.; Tricarico, D. Cell Cycle Regulation by Ca2+-Activated K+ (BK) Channels Modulators in SH-SY5Y Neuroblastoma Cells. Int. J. Mol. Sci. 2018, 19, 2442. [Google Scholar] [CrossRef] [Green Version]
  34. Tolstykh, G.P.; Cantu, J.C.; Tarango, M.; Ibey, B.L. Receptor- and store-operated mechanisms of calcium entry during the nanosecond electric pulse-induced cellular response. Biochim. Biophys. Acta BBA-Biomembr. 2019, 1861, 685–696. [Google Scholar] [CrossRef]
  35. Rorsman, P.; Ashcroft, F.M. Pancreatic beta-Cell Electrical Activity and Insulin Secretion: Of Mice and Men. Physiol. Rev. 2018, 98, 117–214. [Google Scholar] [CrossRef] [Green Version]
  36. Zhou, Y.; Wong, C.O.; Cho, K.J.; van der Hoeven, D.; Liang, H.; Thakur, D.P.; Luo, J.; Babic, M.; Zinsmaier, K.E.; Zhu, M.X.; et al. Membrane potential modulates plasma membrane phospholipid dynamics and K-Ras signaling. Science 2015, 349, 873–876. [Google Scholar] [CrossRef] [Green Version]
  37. Harris, M.P. Bioelectric signaling as a unique regulator of development and regeneration. Development 2021, 148, dev180794. [Google Scholar] [CrossRef]
  38. George, L.F.; Bates, E.A. Mechanisms Underlying Influence of Bioelectricity in Development. Front. Cell. Dev. Biol. 2022, 10, 772230. [Google Scholar] [CrossRef]
  39. Jan, L.Y.; Jan, Y.N. Voltage-gated potassium channels and the diversity of electrical signalling. J. Physiol. 2012, 590, 2591–2599. [Google Scholar] [CrossRef]
  40. Fillafer, C.; Paeger, A.; Schneider, M.F. Collision of two action potentials in a single excitable cell. Biochim. Biophys. Acta Gen. Subj. 2017, 1861, 3282–3286. [Google Scholar] [CrossRef] [Green Version]
  41. Cervera, J.; Meseguer, S.; Mafe, S. Intercellular Connectivity and Multicellular Bioelectric Oscillations in Nonexcitable Cells: A Biophysical Model. ACS Omega 2018, 3, 13567–13575. [Google Scholar] [CrossRef]
  42. Forsberg, A.M.; Bergström, J.; Lindholm, B.; Hultman, E. Resting Membrane Potential of Skeletal Muscle Calculated from Plasma and Muscle Electrolyte and Water Contents. Clin. Sci. 1997, 92, 391–396. [Google Scholar] [CrossRef] [Green Version]
  43. Varro, A.; Tomek, J.; Nagy, N.; Virag, L.; Passini, E.; Rodriguez, B.; Baczko, I. Cardiac transmembrane ion channels and action potentials: Cellular physiology and arrhythmogenic behavior. Physiol. Rev. 2021, 101, 1083–1176. [Google Scholar] [CrossRef]
  44. Kuriyama, H.; Kitamura, K.; Itoh, T.; Inoue, R. Physiological features of visceral smooth muscle cells, with special reference to receptors and ion channels. Physiol. Rev. 1998, 78, 811–920. [Google Scholar] [CrossRef]
  45. Verkhratsky, A.; Nedergaard, M. Physiology of Astroglia. Physiol. Rev. 2018, 98, 239–389. [Google Scholar] [CrossRef]
  46. Spruston, N.; Johnston, D. Perforated patch-clamp analysis of the passive membrane properties of three classes of hippocampal neurons. J. Neurophysiol. 1992, 67, 508–529. [Google Scholar] [CrossRef]
  47. Staley, K.J.; Otis, T.S.; Mody, I. Membrane properties of dentate gyrus granule cells: Comparison of sharp microelectrode and whole-cell recordings. J. Neurophysiol. 1992, 67, 1346–1358. [Google Scholar] [CrossRef]
  48. Matthews, E.K. Membrane potential measurement in cells of the adrenal gland. J. Physiol. 1967, 189, 139–148. [Google Scholar] [CrossRef] [Green Version]
  49. Grinstein, S.; Dixon, S.J. Ion transport, membrane potential, and cytoplasmic pH in lymphocytes: Changes during activation. Physiol. Rev. 1989, 69, 417–481. [Google Scholar] [CrossRef]
  50. Green, S.T.; Petersen, O.H. Thyroid follicular cells: The resting membrane potential and the communication network. Pflug. Arch. 1981, 391, 119–124. [Google Scholar] [CrossRef]
  51. Lewis, R.; Asplin, K.E.; Bruce, G.; Dart, C.; Mobasheri, A.; Barrett-Jolley, R. The role of the membrane potential in chondrocyte volume regulation. J. Cell. Physiol. 2011, 226, 2979–2986. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  52. Ince, C.; Leijh, P.C.; Meijer, J.; Van Bavel, E.; Ypey, D.L. Oscillatory hyperpolarizations and resting membrane potentials of mouse fibroblast and macrophage cell lines. J. Physiol. 1984, 352, 625–635. [Google Scholar] [CrossRef] [PubMed]
  53. Kamkin, A.; Kiseleva, I.; Wagner, K.D.; Lammerich, A.; Bohm, J.; Persson, P.B.; Gunther, J. Mechanically induced potentials in fibroblasts from human right atrium. Exp. Physiol. 1999, 84, 347–356. [Google Scholar] [CrossRef] [PubMed]
  54. Geisler, C.E.; Ghimire, S.; Hepler, C.; Miller, K.E.; Bruggink, S.M.; Kentch, K.P.; Higgins, M.R.; Banek, C.T.; Yoshino, J.; Klein, S.; et al. Hepatocyte membrane potential regulates serum insulin and insulin sensitivity by altering hepatic GABA release. Cell Rep. 2021, 35, 109298. [Google Scholar] [CrossRef]
  55. Yada, T.; Okada, Y. Electrical activity of an intestinal epithelial cell line: Hyperpolarizing responses to intestinal secretagogues. J. Membr. Biol. 1984, 77, 33–44. [Google Scholar] [CrossRef] [PubMed]
  56. Nilius, B.; Schwarz, G.; Droogmans, G. Control of intracellular calcium by membrane potential in human melanoma cells. Am. Physiol. Soc. 1993, 265, C1501–C1510. [Google Scholar] [CrossRef] [PubMed]
  57. Stanisz, H.; Stark, A.; Kilch, T.; Schwarz, E.C.; Müller, C.S.L.; Peinelt, C.; Hoth, M.; Niemeyer, B.A.; Vogt, T.; Bogeski, I. ORAI1 Ca2+ Channels Control Endothelin-1-Induced Mitogenesis and Melanogenesis in Primary Human Melanocytes. J. Investig. Dermatol. 2012, 132, 1443–1451. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  58. Bellono, N.W.; Oancea, E. UV light phototransduction depolarizes human melanocytes. Channels 2013, 7, 243–248. [Google Scholar] [CrossRef] [Green Version]
  59. Bentley, D.C.; Pulbutr, P.; Chan, S.; Smith, P.A. Etiology of the membrane potential of rat white fat adipocytes. Am. J. Physiol. Endocrinol. Metab. 2014, 307, E161–E175. [Google Scholar] [CrossRef] [Green Version]
  60. Pangalos, M.; Bintig, W.; Schlingmann, B.; Feyerabend, F.; Witte, F.; Begandt, D.; Heisterkamp, A.; Ngezahayo, A. Action potentials in primary osteoblasts and in the MG-63 osteoblast-like cell line. J. Bioenerg. Biomembr. 2011, 43, 311–322. [Google Scholar] [CrossRef] [Green Version]
  61. Binggeli, R.; Weinstein, R.C. Membrane potentials and sodium channels: Hypotheses for growth regulation and cancer formation based on changes in sodium channels and gap junctions. J. Theor. Biol. 1986, 123, 377–401. [Google Scholar] [CrossRef]
  62. Yang, M.; Brackenbury, W.J. Membrane potential and cancer progression. Front. Physiol. 2013, 4, 185. [Google Scholar] [CrossRef] [Green Version]
  63. Wright, S.H. Generation of resting membrane potential. Adv. Physiol. Educ. 2004, 28, 139–142. [Google Scholar] [CrossRef]
  64. Stone, M.S.; Martyn, L.; Weaver, C.M. Potassium Intake, Bioavailability, Hypertension, and Glucose Control. Nutrients 2016, 8, 444. [Google Scholar] [CrossRef] [Green Version]
  65. Renigunta, V.; Schlichthörl, G.; Daut, J. Much more than a leak: Structure and function of K2P-channels. Pflüg. Arch. Eur. J. Physiol. 2015, 467, 867–894. [Google Scholar] [CrossRef]
  66. Alexander, S.P.; Mathie, A.; Peters, J.A.; Veale, E.L.; Striessnig, J.; Kelly, E.; Armstrong, J.F.; Faccenda, E.; Harding, S.D.; Pawson, A.J.; et al. THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Ion channels. Br. J. Pharmacol. 2021, 178 (Suppl. S1), S157–S245. [Google Scholar] [CrossRef]
  67. Janata, J. Historical review. Twenty years of ion-selective field-effect transistors. Analyst 1994, 119, 2275–2278. [Google Scholar] [CrossRef]
  68. Hutchings, C.J.; Colussi, P.; Clark, T.G. Ion channels as therapeutic antibody targets. mAbs 2019, 11, 265–296. [Google Scholar] [CrossRef]
  69. Seal, R.L.; Braschi, B.; Gray, K.; Jones, T.E.M.; Tweedie, S.; Haim-Vilmovsky, L.; Bruford, E.A. Genenames.org: The HGNC resources in 2023. Nucleic Acids Res. 2023, 51, D1003–D1009. [Google Scholar] [CrossRef]
  70. Finn, R.N.; Cerda, J. Evolution and functional diversity of aquaporins. Biol. Bull. 2015, 229, 6–23. [Google Scholar] [CrossRef]
  71. Cochet-Bissuel, M.; Lory, P.; Monteil, A. The sodium leak channel, NALCN, in health and disease. Front. Cell. Neurosci. 2014, 8, 132. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  72. Enyedi, P.; Czirjak, G. Molecular background of leak K+ currents: Two-pore domain potassium channels. Physiol. Rev. 2010, 90, 559–605. [Google Scholar] [CrossRef] [Green Version]
  73. Hibino, H.; Inanobe, A.; Furutani, K.; Murakami, S.; Findlay, I.; Kurachi, Y. Inwardly Rectifying Potassium Channels: Their Structure, Function, and Physiological Roles. Physiol. Rev. 2010, 90, 291–366. [Google Scholar] [CrossRef] [Green Version]
  74. Scemes, E.; Spray, D.C.; Meda, P. Connexins, pannexins, innexins: Novel roles of “hemi-channels”. Pflug. Arch. Eur. J. Physiol. 2009, 457, 1207–1226. [Google Scholar] [CrossRef] [Green Version]
  75. Koval, M.; Molina, S.A.; Burt, J.M. Mix and match: Investigating heteromeric and heterotypic gap junction channels in model systems and native tissues. FEBS Lett. 2014, 588, 1193–1204. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  76. Cottrell, G.T.; Burt, J.M. Functional consequences of heterogeneous gap junction channel formation and its influence in health and disease. Biochim. Biophys. Acta BBA-Biomembr. 2005, 1711, 126–141. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  77. Saez, J.C.; Berthoud, V.M.; Branes, M.C.; Martinez, A.D.; Beyer, E.C. Plasma membrane channels formed by connexins: Their regulation and functions. Physiol. Rev. 2003, 83, 1359–1400. [Google Scholar] [CrossRef] [Green Version]
  78. Adams, D.S.; Levin, M. Endogenous voltage gradients as mediators of cell-cell communication: Strategies for investigating bioelectrical signals during pattern formation. Cell Tissue Res. 2013, 352, 95–122. [Google Scholar] [CrossRef] [Green Version]
  79. Eom, D.S.; Bain, E.J.; Patterson, L.B.; Grout, M.E.; Parichy, D.M. Long-distance communication by specialized cellular projections during pigment pattern development and evolution. eLife 2015, 4, e12401. [Google Scholar] [CrossRef]
  80. Sherer, N.M.; Mothes, W. Cytonemes and tunneling nanotubules in cell–cell communication and viral pathogenesis. Trends Cell Biol. 2008, 18, 414–420. [Google Scholar] [CrossRef] [Green Version]
  81. Mese, G.; Richard, G.; White, T.W. Gap junctions: Basic structure and function. J. Investig. Dermatol. 2007, 127, 2516–2524. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  82. Kumar, N.M.; Gilula, N.B. The gap junction communication channel. Cell 1996, 84, 381–388. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  83. Ribeiro-Rodrigues, T.M.; Martins-Marques, T.; Morel, S.; Kwak, B.R.; Girão, H. Role of connexin 43 in different forms of intercellular communication—Gap junctions, extracellular vesicles and tunnelling nanotubes. J. Cell Sci. 2017, 130, 3619–3630. [Google Scholar] [CrossRef] [Green Version]
  84. Lecanda, F.; Warlow, P.M.; Sheikh, S.; Furlan, F.; Steinberg, T.H.; Civitelli, R. Connexin43 Deficiency Causes Delayed Ossification, Craniofacial Abnormalities, and Osteoblast Dysfunction. J. Cell Sci. 2000, 151, 931–944. [Google Scholar] [CrossRef] [Green Version]
  85. Srinivas, M.; Verselis, V.K.; White, T.W. Human diseases associated with connexin mutations. Biochim. Biophys. Acta BBA-Biomembr. 2018, 1860, 192–201. [Google Scholar] [CrossRef] [PubMed]
  86. Pizzagalli, M.D.; Bensimon, A.; Superti-Furga, G. A guide to plasma membrane solute carrier proteins. FEBS J. 2021, 288, 2784–2835. [Google Scholar] [CrossRef] [PubMed]
  87. Alexander, S.P.; Kelly, E.; Mathie, A.; Peters, J.A.; Veale, E.L.; Armstrong, J.F.; Faccenda, E.; Harding, S.D.; Pawson, A.J.; Southan, C.; et al. THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Transporters. Br. J. Pharmacol. 2021, 178 (Suppl. S1), S412–S513. [Google Scholar] [CrossRef] [PubMed]
  88. Lin, L.; Yee, S.W.; Kim, R.B.; Giacomini, K.M. SLC transporters as therapeutic targets: Emerging opportunities. Nat. Rev. Drug. Discov. 2015, 14, 543–560. [Google Scholar] [CrossRef] [Green Version]
  89. Grunwald, D.J.; Eisen, J.S. Headwaters of the zebrafish—Emergence of a new model vertebrate. Nat. Rev. Genet. 2002, 3, 717–724. [Google Scholar] [CrossRef]
  90. Lieschke, G.J.; Currie, P.D. Animal models of human disease: Zebrafish swim into view. Nat. Rev. Genet. 2007, 8, 353–367. [Google Scholar] [CrossRef]
  91. Liu, S.; Leach, S.D. Zebrafish models for cancer. Annu. Rev. Pathol. 2011, 6, 71–93. [Google Scholar] [CrossRef]
  92. Howe, K.; Clark, M.D.; Torroja, C.F.; Torrance, J.; Berthelot, C.; Muffato, M.; Collins, J.E.; Humphray, S.; McLaren, K.; Matthews, L.; et al. The zebrafish reference genome sequence and its relationship to the human genome. Nature 2013, 496, 498–503. [Google Scholar] [CrossRef] [Green Version]
  93. Li, M.; Zhao, L.; Page-McCaw, P.S.; Chen, W. Zebrafish Genome Engineering Using the CRISPR-Cas9 System. Trends Genet. 2016, 32, 815–827. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  94. Lawson, N.D.; Wolfe, S.A. Forward and reverse genetic approaches for the analysis of vertebrate development in the zebrafish. Dev. Cell 2011, 21, 48–64. [Google Scholar] [CrossRef] [Green Version]
  95. Kawakami, K. Tol2: A versatile gene transfer vector in vertebrates. Genome Biol. 2007, 8 (Suppl. S1), S7. [Google Scholar] [CrossRef] [Green Version]
  96. Sprague, J.; Clements, D.; Conlin, T.; Edwards, P.; Frazer, K.; Schaper, K.; Segerdell, E.; Song, P.; Sprunger, B.; Westerfield, M. The Zebrafish Information Network (ZFIN): The zebrafish model organism database. Nucleic Acids Res. 2003, 31, 241–243. [Google Scholar] [CrossRef]
  97. Sprague, J.; Doerry, E.; Douglas, S.; Westerfield, M. The Zebrafish Information Network (ZFIN): A resource for genetic, genomic and developmental research. Nucleic Acids Res. 2001, 29, 87–90. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  98. Santoriello, C.; Zon, L.I. Hooked! Modeling human disease in zebrafish. J. Clin. Investig. 2012, 122, 2337–2343. [Google Scholar] [CrossRef] [Green Version]
  99. Veldman, M.B.; Lin, S. Zebrafish as a Developmental Model Organism for Pediatric Research. Pediatr. Res. 2008, 64, 470–476. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  100. Grandel, H.; Schulte-Merker, S. The development of the paired fins in the zebrafish (Danio rerio). Mech. Dev. 1998, 79, 99–120. [Google Scholar] [CrossRef] [PubMed]
  101. Pfefferli, C.; Jazwinska, A. The art of fin regeneration in zebrafish. Regeneration 2015, 2, 72–83. [Google Scholar] [CrossRef] [PubMed]
  102. Mabee, P.M.; Crotwell, P.L.; Bird, N.C.; Burke, A.C. Evolution of median fin modules in the axial skeleton of fishes. J. Exp. Zool. 2002, 294, 77–90. [Google Scholar] [CrossRef] [PubMed]
  103. Mari-Beffa, M.; Murciano, C. Dermoskeleton morphogenesis in zebrafish fins. Dev. Dyn. 2010, 239, 2779–2794. [Google Scholar] [CrossRef] [Green Version]
  104. Yano, T.; Abe, G.; Yokoyama, H.; Kawakami, K.; Tamura, K. Mechanism of pectoral fin outgrowth in zebrafish development. Development 2012, 139, 2916–2925. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  105. Stewart, S.; Le Bleu, H.K.; Yette, G.A.; Henner, A.L.; Robbins, A.E.; Braunstein, J.A.; Stankunas, K. longfin causes cis-ectopic expression of the kcnh2a ether-a-go-go K+ channel to autonomously prolong fin outgrowth. Development 2021, 148, dev199384. [Google Scholar] [CrossRef]
  106. Daane, J.M.; Blum, N.; Lanni, J.; Boldt, H.; Iovine, M.K.; Higdon, C.W.; Johnson, S.L.; Lovejoy, N.R.; Harris, M.P. Modulation of bioelectric cues in the evolution of flying fishes. Curr. Biol. 2021, 31, 5052–5061.e8. [Google Scholar] [CrossRef] [PubMed]
  107. Perathoner, S.; Daane, J.M.; Henrion, U.; Seebohm, G.; Higdon, C.W.; Johnson, S.L.; Nüsslein-Volhard, C.; Harris, M.P. Bioelectric Signaling Regulates Size in Zebrafish Fins. PLoS Genet. 2014, 10, e1004080. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  108. Lanni, J.S.; Peal, D.; Ekstrom, L.; Chen, H.; Stanclift, C.; Bowen, M.E.; Mercado, A.; Gamba, G.; Kahle, K.T.; Harris, M.P. Integrated K+ channel and K+Cl cotransporter functions are required for the coordination of size and proportion during development. Dev. Biol. 2019, 456, 164–178. [Google Scholar] [CrossRef]
  109. Iovine, M.K.; Higgins, E.P.; Hindes, A.; Coblitz, B.; Johnson, S.L. Mutations in connexin43 (GJA1) perturb bone growth in zebrafish fins. Dev. Biol. 2005, 278, 208–219. [Google Scholar] [CrossRef] [Green Version]
  110. Eskova, A.; Chauvigné, F.; Maischein, H.-M.; Ammelburg, M.; Cerdà, J.; Nüsslein-Volhard, C.; Irion, U. Gain-of-function mutations in Aqp3a influence zebrafish pigment pattern formation through the tissue environment. Development 2017, 144, 2059–2069. [Google Scholar] [CrossRef] [Green Version]
  111. Iovine, M.K.; Johnson, S.L. Genetic analysis of isometric growth control mechanisms in the zebrafish caudal Fin. Genetics 2000, 155, 1321–1329. [Google Scholar] [CrossRef] [PubMed]
  112. Silic, M.R.; Wu, Q.; Kim, B.H.; Golling, G.; Chen, K.H.; Freitas, R.; Chubykin, A.A.; Mittal, S.K.; Zhang, G. Potassium Channel-Associated Bioelectricity of the Dermomyotome Determines Fin Patterning in Zebrafish. Genetics 2020, 215, 1067–1084. [Google Scholar] [CrossRef]
  113. Zhang, W.; Wang, H.; Brandt, D.Y.C.; Hu, B.; Sheng, J.; Wang, M.; Luo, H.; Li, Y.; Guo, S.; Sheng, B.; et al. The genetic architecture of phenotypic diversity in the Betta fish (Betta splendens). Sci. Adv. 2022, 8, eabm4955. [Google Scholar] [CrossRef]
  114. Schartl, M.; Kneitz, S.; Ormanns, J.; Schmidt, C.; Anderson, J.L.; Amores, A.; Catchen, J.; Wilson, C.; Geiger, D.; Du, K.; et al. The Developmental and Genetic Architecture of the Sexually Selected Male Ornament of Swordtails. Curr. Biol. 2021, 31, 911–922.e4. [Google Scholar] [CrossRef] [PubMed]
  115. Kon, T.; Omori, Y.; Fukuta, K.; Wada, H.; Watanabe, M.; Chen, Z.; Iwasaki, M.; Mishina, T.; Matsuzaki, S.S.; Yoshihara, D.; et al. The Genetic Basis of Morphological Diversity in Domesticated Goldfish. Curr. Biol. 2020, 30, 2260–2274.e6. [Google Scholar] [CrossRef]
  116. Singh, A.P.; Nüsslein-Volhard, C. Zebrafish Stripes as a Model for Vertebrate Colour Pattern Formation. Curr. Biol. 2015, 25, R81–R92. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  117. Patterson, L.B.; Parichy, D.M. Zebrafish Pigment Pattern Formation: Insights into the Development and Evolution of Adult Form. Annu. Rev. Genet. 2019, 53, 505–530. [Google Scholar] [CrossRef] [PubMed]
  118. McGowan, K.A.; Barsh, G.S. How the zebrafish got its stripes. eLife 2016, 5, e14239. [Google Scholar] [CrossRef]
  119. Dooley, C.M.; Schwarz, H.; Mueller, K.P.; Mongera, A.; Konantz, M.; Neuhauss, S.C.; Nusslein-Volhard, C.; Geisler, R. Slc45a2 and V-ATPase are regulators of melanosomal pH homeostasis in zebrafish, providing a mechanism for human pigment evolution and disease. Pigment. Cell Melanoma Res. 2013, 26, 205–217. [Google Scholar] [CrossRef]
  120. Lamason, R.L.; Mohideen, M.A.; Mest, J.R.; Wong, A.C.; Norton, H.L.; Aros, M.C.; Jurynec, M.J.; Mao, X.; Humphreville, V.R.; Humbert, J.E.; et al. SLC24A5, a putative cation exchanger, affects pigmentation in zebrafish and humans. Science 2005, 310, 1782–1786. [Google Scholar] [CrossRef] [Green Version]
  121. Le, L.; Escobar, I.E.; Ho, T.; Lefkovith, A.J.; Latteri, E.; Haltaufderhyde, K.D.; Dennis, M.K.; Plowright, L.; Sviderskaya, E.V.; Bennett, D.C.; et al. SLC45A2 protein stability and regulation of melanosome pH determine melanocyte pigmentation. Mol. Biol. Cell 2020, 31, 2687–2702. [Google Scholar] [CrossRef] [PubMed]
  122. D’Agati, G.; Beltre, R.; Sessa, A.; Burger, A.; Zhou, Y.; Mosimann, C.; White, R.M. A defect in the mitochondrial protein Mpv17 underlies the transparent casper zebrafish. Dev. Biol. 2017, 430, 11–17. [Google Scholar] [CrossRef]
  123. Antonenkov, V.D.; Isomursu, A.; Mennerich, D.; Vapola, M.H.; Weiher, H.; Kietzmann, T.; Hiltunen, J.K. The Human Mitochondrial DNA Depletion Syndrome Gene MPV17 Encodes a Non-selective Channel That Modulates Membrane Potential. J. Biol. Chem. 2015, 290, 13840–13861. [Google Scholar] [CrossRef] [Green Version]
  124. Irion, U.; Frohnhöfer, H.G.; Krauss, J.; Çolak Champollion, T.; Maischein, H.-M.; Geiger-Rudolph, S.; Weiler, C.; Nüsslein-Volhard, C. Gap junctions composed of connexins 41.8 and 39.4 are essential for colour pattern formation in zebrafish. eLife 2014, 3, e05125. [Google Scholar] [CrossRef]
  125. Watanabe, M.; Sawada, R.; Aramaki, T.; Skerrett, I.M.; Kondo, S. The Physiological Characterization of Connexin41.8 and Connexin39.4, Which Are Involved in the Striped Pattern Formation of Zebrafish. J. Biol. Chem. 2016, 291, 1053–1063. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  126. Iwashita, M.; Watanabe, M.; Ishii, M.; Chen, T.; Johnson, S.L.; Kurachi, Y.; Okada, N.; Kondo, S. Pigment Pattern in jaguar/obelix Zebrafish Is Caused by a Kir7.1 Mutation: Implications for the Regulation of Melanosome Movement. PLoS Genet. 2006, 2, e197. [Google Scholar] [CrossRef] [PubMed]
  127. Podobnik, M.; Frohnhofer, H.G.; Dooley, C.M.; Eskova, A.; Nusslein-Volhard, C.; Irion, U. Evolution of the potassium channel gene Kcnj13 underlies colour pattern diversification in Danio fish. Nat. Commun. 2020, 11, 6230. [Google Scholar] [CrossRef]
  128. Inaba, M.; Yamanaka, H.; Kondo, S. Pigment Pattern Formation by Contact-Dependent Depolarization. Science 2012, 335, 677. [Google Scholar] [CrossRef] [Green Version]
  129. Williams, K. Interactions of polyamines with ion channels. Biochem. J. 1997, 325 Pt 2, 289–297. [Google Scholar] [CrossRef] [Green Version]
  130. Nichols, C.G.; Lee, S.J. Polyamines and potassium channels: A 25-year romance. J. Biol. Chem. 2018, 293, 18779–18788. [Google Scholar] [CrossRef] [Green Version]
  131. Frohnhofer, H.G.; Geiger-Rudolph, S.; Pattky, M.; Meixner, M.; Huhn, C.; Maischein, H.M.; Geisler, R.; Gehring, I.; Maderspacher, F.; Nusslein-Volhard, C.; et al. Spermidine, but not spermine, is essential for pigment pattern formation in zebrafish. Biol. Open 2016, 5, 736–744. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  132. Watanabe, M.; Watanabe, D.; Kondo, S. Polyamine sensitivity of gap junctions is required for skin pattern formation in zebrafish. Sci. Rep. 2012, 2, 473. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  133. Fadeev, A.; Krauss, J.; Frohnhofer, H.G.; Irion, U.; Nusslein-Volhard, C. Tight Junction Protein 1a regulates pigment cell organisation during zebrafish colour patterning. eLife 2015, 4, e06545. [Google Scholar] [CrossRef]
  134. Verkman, A.S. Aquaporins at a glance. J. Cell Sci. 2011, 124, 2107–2112. [Google Scholar] [CrossRef] [Green Version]
  135. Mollinedo-Gajate, I.; Song, C.; Knopfel, T. Genetically Encoded Voltage Indicators. Adv. Exp. Med. Biol. 2021, 1293, 209–224. [Google Scholar] [CrossRef] [PubMed]
  136. Choe, M.; Titov, D.V. Genetically encoded tools for measuring and manipulating metabolism. Nat. Chem. Biol. 2022, 18, 451–460. [Google Scholar] [CrossRef]
  137. Poth, K.M.; Texakalidis, P.; Boulis, N.M. Chemogenetics: Beyond Lesions and Electrodes. Neurosurgery 2021, 89, 185–195. [Google Scholar] [CrossRef]
  138. Ozawa, A.; Arakawa, H. Chemogenetics drives paradigm change in the investigation of behavioral circuits and neural mechanisms underlying drug action. Behav. Brain Res. 2021, 406, 113234. [Google Scholar] [CrossRef]
  139. Keifer, O.; Kambara, K.; Lau, A.; Makinson, S.; Bertrand, D. Chemogenetics a robust approach to pharmacology and gene therapy. Biochem. Pharmacol. 2020, 175, 113889. [Google Scholar] [CrossRef]
  140. Chen, W.; Li, C.; Liang, W.; Li, Y.; Zou, Z.; Xie, Y.; Liao, Y.; Yu, L.; Lin, Q.; Huang, M.; et al. The Roles of Optogenetics and Technology in Neurobiology: A Review. Front. Aging Neurosci. 2022, 14, 867863. [Google Scholar] [CrossRef]
  141. Antinucci, P.; Dumitrescu, A.; Deleuze, C.; Morley, H.J.; Leung, K.; Hagley, T.; Kubo, F.; Baier, H.; Bianco, I.H.; Wyart, C. A calibrated optogenetic toolbox of stable zebrafish opsin lines. eLife 2020, 9, e54937. [Google Scholar] [CrossRef] [PubMed]
  142. Josselyn, S.A. The past, present and future of light-gated ion channels and optogenetics. eLife 2018, 7, e42367. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  143. Deisseroth, K. Optogenetics: 10 years of microbial opsins in neuroscience. Nat. Neurosci. 2015, 18, 1213–1225. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  144. Zhang, G.; Cui, J. Patch-Clamp and Perfusion Techniques to Study Ion Channels Expressed in Xenopus Oocytes. Cold Spring Harb. Protoc. 2018, 2018, pdb.prot099051. [Google Scholar] [CrossRef] [PubMed]
  145. Lin, M.Z.; Schnitzer, M.J. Genetically encoded indicators of neuronal activity. Nat. Neurosci. 2016, 19, 1142–1153. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  146. Noguchi, A.; Ikegaya, Y.; Matsumoto, N. In Vivo Whole-Cell Patch-Clamp Methods: Recent Technical Progress and Future Perspectives. Sensors 2021, 21, 1448. [Google Scholar] [CrossRef]
  147. Muto, A.; Kawakami, K. Imaging functional neural circuits in zebrafish with a new GCaMP and the Gal4FF-UAS system. Commun. Integr. Biol. 2011, 4, 566–568. [Google Scholar] [CrossRef]
  148. Kim, C.K.; Miri, A.; Leung, L.C.; Berndt, A.; Mourrain, P.; Tank, D.W.; Burdine, R.D. Prolonged, brain-wide expression of nuclear-localized GCaMP3 for functional circuit mapping. Front. Neural Circuits 2014, 8, 138. [Google Scholar] [CrossRef] [Green Version]
  149. DeMarco, E.; Xu, N.; Baier, H.; Robles, E. Neuron types in the zebrafish optic tectum labeled by an id2b transgene. J. Comp. Neurol. 2020, 528, 1173–1188. [Google Scholar] [CrossRef] [Green Version]
  150. Beerman, R.W.; Matty, M.A.; Au, G.G.; Looger, L.L.; Choudhury, K.R.; Keller, P.J.; Tobin, D.M. Direct In Vivo Manipulation and Imaging of Calcium Transients in Neutrophils Identify a Critical Role for Leading-Edge Calcium Flux. Cell Rep. 2015, 13, 2107–2117. [Google Scholar] [CrossRef] [Green Version]
  151. Shelef, M.A.; Tauzin, S.; Huttenlocher, A. Neutrophil migration: Moving from zebrafish models to human autoimmunity. Immunol. Rev. 2013, 256, 269–281. [Google Scholar] [CrossRef] [Green Version]
  152. Mizuno, H.; Sassa, T.; Higashijima, S.; Okamoto, H.; Miyawaki, A. Transgenic zebrafish for ratiometric imaging of cytosolic and mitochondrial Ca2+ response in teleost embryo. Cell Calcium 2013, 54, 236–245. [Google Scholar] [CrossRef] [PubMed]
  153. Chen, J.; Xia, L.; Bruchas, M.R.; Solnica-Krezel, L. Imaging early embryonic calcium activity with GCaMP6s transgenic zebrafish. Dev. Biol. 2017, 430, 385–396. [Google Scholar] [CrossRef] [PubMed]
  154. Lorincz, R.; Emfinger, C.H.; Walcher, A.; Giolai, M.; Krautgasser, C.; Remedi, M.S.; Nichols, C.G.; Meyer, D. In vivo monitoring of intracellular Ca2+ dynamics in the pancreatic beta-cells of zebrafish embryos. Islets 2018, 10, 221–238. [Google Scholar] [CrossRef] [Green Version]
  155. Li, F.; Long, Y.; Xie, J.; Ren, J.; Zhou, T.; Song, G.; Li, Q.; Cui, Z. Generation of GCaMP6s-Expressing Zebrafish to Monitor Spatiotemporal Dynamics of Calcium Signaling Elicited by Heat Stress. Int. J. Mol. Sci. 2021, 22, 5551. [Google Scholar] [CrossRef] [PubMed]
  156. Pozo-Morales, M.; Garteizgogeascoa, I.; Perazzolo, C.; So, J.; Shin, D.; Singh, S.P. In vivo imaging of calcium dynamics in zebrafish hepatocytes. Hepatology 2022, 77, 789–801. [Google Scholar] [CrossRef]
  157. Kettunen, P. Calcium Imaging in the Zebrafish. Adv. Exp. Med. Biol. 2020, 1131, 901–942. [Google Scholar] [CrossRef]
  158. Lukasz, D.; Kindt, K.S. In Vivo Calcium Imaging of Lateral-line Hair Cells in Larval Zebrafish. J. Vis. Exp. 2018, e58794. [Google Scholar] [CrossRef] [Green Version]
  159. Debnath, A.; Williams, P.D.E.; Bamber, B.A. Reduced Ca(2+) transient amplitudes may signify increased or decreased depolarization depending on the neuromodulatory signaling pathway. Front. Neurosci. 2022, 16, 931328. [Google Scholar] [CrossRef]
  160. Zhu, M.H.; Jang, J.; Milosevic, M.M.; Antic, S.D. Population imaging discrepancies between a genetically-encoded calcium indicator (GECI) versus a genetically-encoded voltage indicator (GEVI). Sci. Rep. 2021, 11, 5295. [Google Scholar] [CrossRef]
  161. Gest, A.M.M.; Yaeger-Weiss, S.K.; Lazzari-Dean, J.R.; Miller, E.W. VoltageFluor dyes and fluorescence lifetime imaging for optical measurement of membrane potential. In Methods in Enzymology; Minor, D.L., Colecraft, H.M., Eds.; Ion Channels: Channel Production and Optical Methods; Academic Press: Cambridge, MA, USA, 2021; Volume 653, pp. 267–293. [Google Scholar]
  162. Yang, H.H.; St-Pierre, F. Genetically Encoded Voltage Indicators: Opportunities and Challenges. J. Neurosci. 2016, 36, 9977–9989. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  163. Platisa, J.; Pieribone, V.A. Genetically encoded fluorescent voltage indicators: Are we there yet? Curr. Opin. Neurobiol. 2018, 50, 146–153. [Google Scholar] [CrossRef]
  164. Sakata, S.; Okamura, Y. Phosphatase activity of the voltage-sensing phosphatase, VSP, shows graded dependence on the extent of activation of the voltage sensor. J. Physiol. 2014, 592, 899–914. [Google Scholar] [CrossRef] [PubMed]
  165. Tsutsui, H.; Jinno, Y.; Tomita, A.; Niino, Y.; Yamada, Y.; Mikoshiba, K.; Miyawaki, A.; Okamura, Y. Improved detection of electrical activity with a voltage probe based on a voltage-sensing phosphatase. J. Physiol. 2013, 591, 4427–4437. [Google Scholar] [CrossRef]
  166. St-Pierre, F.; Marshall, J.D.; Yang, Y.; Gong, Y.; Schnitzer, M.J.; Lin, M.Z. High-fidelity optical reporting of neuronal electrical activity with an ultrafast fluorescent voltage sensor. Nat. Neurosci. 2014, 17, 884–889. [Google Scholar] [CrossRef] [Green Version]
  167. Chamberland, S.; Yang, H.H.; Pan, M.M.; Evans, S.W.; Guan, S.; Chavarha, M.; Yang, Y.; Salesse, C.; Wu, H.; Wu, J.C.; et al. Fast two-photon imaging of subcellular voltage dynamics in neuronal tissue with genetically encoded indicators. eLife 2017, 6, e25690. [Google Scholar] [CrossRef]
  168. Villette, V.; Chavarha, M.; Dimov, I.K.; Bradley, J.; Pradhan, L.; Mathieu, B.; Evans, S.W.; Chamberland, S.; Shi, D.; Yang, R.; et al. Ultrafast Two-Photon Imaging of a High-Gain Voltage Indicator in Awake Behaving Mice. Cell 2019, 179, 1590–1608.e23. [Google Scholar] [CrossRef] [PubMed]
  169. Yang, H.H.; St-Pierre, F.; Sun, X.; Ding, X.; Lin, M.Z.; Clandinin, T.R. Subcellular Imaging of Voltage and Calcium Signals Reveals Neural Processing In Vivo. Cell 2016, 166, 245–257. [Google Scholar] [CrossRef] [Green Version]
  170. Silic, M.R.; Zhang, G. Visualization of Cellular Electrical Activity in Zebrafish Early Embryos and Tumors. J. Vis. Exp. 2018, e57330. [Google Scholar] [CrossRef]
  171. Silic, M.R.; Dong, Z.; Chen, Y.; Kimbrough, A.; Zhang, G. Zebrafish Embryos Display Characteristic Bioelectric Signals during Early Development. Cells 2022, 11, 3586. [Google Scholar] [CrossRef] [PubMed]
  172. Hiyoshi, K.; Shiraishi, A.; Fukuda, N.; Tsuda, S. In vivo wide-field voltage imaging in zebrafish with voltage-sensitive dye and genetically encoded voltage indicator. Dev. Growth Differ. 2021, 63, 417–428. [Google Scholar] [CrossRef] [PubMed]
  173. Miyazawa, H.; Okumura, K.; Hiyoshi, K.; Maruyama, K.; Kakinuma, H.; Amo, R.; Okamoto, H.; Yamasu, K.; Tsuda, S. Optical interrogation of neuronal circuitry in zebrafish using genetically encoded voltage indicators. Sci. Rep. 2018, 8, 6048. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  174. Liu, J.; Fairn, G.D.; Ceccarelli, D.F.; Sicheri, F.; Wilde, A. Cleavage Furrow Organization Requires PIP2-Mediated Recruitment of Anillin. Curr. Biol. 2012, 22, 64–69. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  175. Field, S.J.; Madson, N.; Kerr, M.L.; Galbraith, K.A.A.; Kennedy, C.E.; Tahiliani, M.; Wilkins, A.; Cantley, L.C. PtdIns(4,5)P2 Functions at the Cleavage Furrow during Cytokinesis. Curr. Biol. 2005, 15, 1407–1412. [Google Scholar] [CrossRef] [Green Version]
  176. Raccuglia, D.; Huang, S.; Ender, A.; Heim, M.M.; Laber, D.; Suárez-Grimalt, R.; Liotta, A.; Sigrist, S.J.; Geiger, J.R.P.; Owald, D. Network-Specific Synchronization of Electrical Slow-Wave Oscillations Regulates Sleep Drive in Drosophila. Curr. Biol. 2019, 29, 3611–3621.e3. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  177. Raccuglia, D.; McCurdy, L.Y.; Demir, M.; Gorur-Shandilya, S.; Kunst, M.; Emonet, T.; Nitabach, M.N. Presynaptic GABA Receptors Mediate Temporal Contrast Enhancement in Drosophila Olfactory Sensory Neurons and Modulate Odor-Driven Behavioral Kinetics. eNeuro 2016, 3, ENEURO.0080-0016. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  178. Liu, Z.; Lu, X.; Villette, V.; Gou, Y.; Colbert, K.L.; Lai, S.; Guan, S.; Land, M.A.; Lee, J.; Assefa, T.; et al. Sustained deep-tissue voltage recording using a fast indicator evolved for two-photon microscopy. Cell 2022, 185, 3408–3425.e29. [Google Scholar] [CrossRef]
  179. Shimaoka, D.; Steinmetz, N.A.; Harris, K.D.; Carandini, M. The impact of bilateral ongoing activity on evoked responses in mouse cortex. eLife 2019, 8, e43533. [Google Scholar] [CrossRef]
  180. Song, C.; Piscopo, D.M.; Niell, C.M.; Knopfel, T. Cortical signatures of wakeful somatosensory processing. Sci. Rep. 2018, 8, 11977. [Google Scholar] [CrossRef] [Green Version]
  181. Platisa, J.; Zeng, H.; Madisen, L.; Cohen, L.B.; Pieribone, V.A.; Storace, D.A. Voltage imaging in the olfactory bulb using transgenic mouse lines expressing the genetically encoded voltage indicator ArcLight. Sci. Rep. 2022, 12, 1875. [Google Scholar] [CrossRef]
  182. Kannan, M.; Vasan, G.; Haziza, S.; Huang, C.; Chrapkiewicz, R.; Luo, J.; Cardin, J.A.; Schnitzer, M.J.; Pieribone, V.A. Dual-polarity voltage imaging of the concurrent dynamics of multiple neuron types. Science 2022, 378, eabm8797. [Google Scholar] [CrossRef] [PubMed]
  183. Treger, J.S.; Priest, M.F.; Bezanilla, F. Single-molecule fluorimetry and gating currents inspire an improved optical voltage indicator. eLife 2015, 4, e10482. [Google Scholar] [CrossRef]
  184. Zhang, Y.; Shannonhouse, J.; Gomez, R.; Son, H.; Ishida, H.; Evans, S.; Chavarha, M.; Shi, D.; Zhang, G.; Lin, M.Z.; et al. Imaging sensory transmission and neuronal plasticity in primary sensory neurons with genetically-encoded voltage indicator, ASAP4.4-Kv. bioRxiv 2021. [Google Scholar] [CrossRef]
  185. Evans, S.W.; Shi, D.; Chavarha, M.; Plitt, M.H.; Taxidis, J.; Madruga, B.; van Keulen, S.C.; Pang, M.M.; Su, S.; Hwang, F.-J.; et al. A positively Tuned Voltage Indicator Reveals Electrical Correlates of Calcium Activity in the Brain. bioRxiv 2022. [Google Scholar] [CrossRef]
  186. Platisa, J.; Vasan, G.; Yang, A.; Pieribone, V.A. Directed Evolution of Key Residues in Fluorescent Protein Inverses the Polarity of Voltage Sensitivity in the Genetically Encoded Indicator ArcLight. ACS Chem. Neurosci. 2017, 8, 513–523. [Google Scholar] [CrossRef] [Green Version]
  187. Abdelfattah, A.S.; Farhi, S.L.; Zhao, Y.; Brinks, D.; Zou, P.; Ruangkittisakul, A.; Platisa, J.; Pieribone, V.A.; Ballanyi, K.; Cohen, A.E.; et al. A Bright and Fast Red Fluorescent Protein Voltage Indicator That Reports Neuronal Activity in Organotypic Brain Slices. J. Neurosci. 2016, 36, 2458–2472. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  188. Jin, L.; Han, Z.; Platisa, J.; Wooltorton, J.R.; Cohen, L.B.; Pieribone, V.A. Single Action Potentials and Subthreshold Electrical Events Imaged in Neurons with a Fluorescent Protein Voltage Probe. Neuron 2012, 75, 779–785. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  189. Han, Z.; Jin, L.; Platisa, J.; Cohen, L.B.; Baker, B.J.; Pieribone, V.A. Fluorescent protein voltage probes derived from ArcLight that respond to membrane voltage changes with fast kinetics. PLoS ONE 2013, 8, e81295. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  190. Lee, S.; Geiller, T.; Jung, A.; Nakajima, R.; Song, Y.K.; Baker, B.J. Improving a genetically encoded voltage indicator by modifying the cytoplasmic charge composition. Sci. Rep. 2017, 7, 8286. [Google Scholar] [CrossRef] [Green Version]
  191. Kibat, C.; Krishnan, S.; Ramaswamy, M.; Baker, B.J.; Jesuthasan, S. Imaging voltage in zebrafish as a route to characterizing a vertebrate functional connectome: Promises and pitfalls of genetically encoded indicators. J. Neurogenet. 2016, 30, 80–88. [Google Scholar] [CrossRef]
  192. Sepehri Rad, M.; Cohen, L.B.; Braubach, O.; Baker, B.J. Monitoring voltage fluctuations of intracellular membranes. Sci. Rep. 2018, 8, 6911. [Google Scholar] [CrossRef] [Green Version]
  193. Akemann, W.; Mutoh, H.; Perron, A.; Rossier, J.; Knopfel, T. Imaging brain electric signals with genetically targeted voltage-sensitive fluorescent proteins. Nat. Methods 2010, 7, 643–649. [Google Scholar] [CrossRef]
  194. Lam, A.J.; St-Pierre, F.; Gong, Y.; Marshall, J.D.; Cranfill, P.J.; Baird, M.A.; McKeown, M.R.; Wiedenmann, J.; Davidson, M.W.; Schnitzer, M.J.; et al. Improving FRET dynamic range with bright green and red fluorescent proteins. Nat. Methods 2012, 9, 1005–1012. [Google Scholar] [CrossRef] [Green Version]
  195. Akemann, W.; Mutoh, H.; Perron, A.; Park, Y.K.; Iwamoto, Y.; Knopfel, T. Imaging neural circuit dynamics with a voltage-sensitive fluorescent protein. J. Neurophysiol. 2012, 108, 2323–2337. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  196. Mishina, Y.; Mutoh, H.; Song, C.; Knopfel, T. Exploration of genetically encoded voltage indicators based on a chimeric voltage sensing domain. Front. Mol. Neurosci. 2014, 7, 78. [Google Scholar] [CrossRef] [Green Version]
  197. Gautam, S.G.; Perron, A.; Mutoh, H.; Knopfel, T. Exploration of fluorescent protein voltage probes based on circularly permuted fluorescent proteins. Front. Neuroeng. 2009, 2, 14. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  198. Perron, A.; Mutoh, H.; Launey, T.; Knopfel, T. Red-shifted voltage-sensitive fluorescent proteins. Chem. Biol. 2009, 16, 1268–1277. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  199. van Opbergen, C.J.M.; Koopman, C.D.; Kok, B.J.M.; Knopfel, T.; Renninger, S.L.; Orger, M.B.; Vos, M.A.; van Veen, T.A.B.; Bakkers, J.; de Boer, T.P. Optogenetic sensors in the zebrafish heart: A novel in vivo electrophysiological tool to study cardiac arrhythmogenesis. Theranostics 2018, 8, 4750–4764. [Google Scholar] [CrossRef] [PubMed]
  200. Koopman, C.D.; De Angelis, J.; Iyer, S.P.; Verkerk, A.O.; Da Silva, J.; Berecki, G.; Jeanes, A.; Baillie, G.J.; Paterson, S.; Uribe, V.; et al. The zebrafish grime mutant uncovers an evolutionarily conserved role for Tmem161b in the control of cardiac rhythm. Proc. Natl. Acad. Sci. USA 2021, 118, e2018220118. [Google Scholar] [CrossRef]
  201. Tsutsui, H.; Karasawa, S.; Okamura, Y.; Miyawaki, A. Improving membrane voltage measurements using FRET with new fluorescent proteins. Nat. Methods 2008, 5, 683–685. [Google Scholar] [CrossRef]
  202. Sung, U.; Sepehri-Rad, M.; Piao, H.H.; Jin, L.; Hughes, T.; Cohen, L.B.; Baker, B.J. Developing Fast Fluorescent Protein Voltage Sensors by Optimizing FRET Interactions. PLoS ONE 2015, 10, e0141585. [Google Scholar] [CrossRef] [Green Version]
  203. Kralj, J.M.; Douglass, A.D.; Hochbaum, D.R.; Maclaurin, D.; Cohen, A.E. Optical recording of action potentials in mammalian neurons using a microbial rhodopsin. Nat. Methods 2012, 9, 90–95. [Google Scholar] [CrossRef] [Green Version]
  204. Hochbaum, D.R.; Zhao, Y.; Farhi, S.L.; Klapoetke, N.; Werley, C.A.; Kapoor, V.; Zou, P.; Kralj, J.M.; Maclaurin, D.; Smedemark-Margulies, N.; et al. All-optical electrophysiology in mammalian neurons using engineered microbial rhodopsins. Nat. Methods 2014, 11, 825–833. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  205. Adam, Y.; Kim, J.J.; Lou, S.; Zhao, Y.; Xie, M.E.; Brinks, D.; Wu, H.; Mostajo-Radji, M.A.; Kheifets, S.; Parot, V.; et al. Voltage imaging and optogenetics reveal behaviour-dependent changes in hippocampal dynamics. Nature 2019, 569, 413–417. [Google Scholar] [CrossRef] [Green Version]
  206. Zou, P.; Zhao, Y.; Douglass, A.D.; Hochbaum, D.R.; Brinks, D.; Werley, C.A.; Harrison, D.J.; Campbell, R.E.; Cohen, A.E. Bright and fast multicoloured voltage reporters via electrochromic FRET. Nat. Commun. 2014, 5, 4625. [Google Scholar] [CrossRef] [Green Version]
  207. Hou, J.H.; Kralj, J.M.; Douglass, A.D.; Engert, F.; Cohen, A.E. Simultaneous mapping of membrane voltage and calcium in zebrafish heart in vivo reveals chamber-specific developmental transitions in ionic currents. Front. Physiol. 2014, 5, 344. [Google Scholar] [CrossRef] [Green Version]
  208. Dempsey, G.T.; Chaudhary, K.W.; Atwater, N.; Nguyen, C.; Brown, B.S.; McNeish, J.D.; Cohen, A.E.; Kralj, J.M. Cardiotoxicity screening with simultaneous optogenetic pacing, voltage imaging and calcium imaging. J. Pharmacol. Toxicol. Methods 2016, 81, 240–250. [Google Scholar] [CrossRef]
  209. Piatkevich, K.D.; Jung, E.E.; Straub, C.; Linghu, C.; Park, D.; Suk, H.-J.; Hochbaum, D.R.; Goodwin, D.; Pnevmatikakis, E.; Pak, N.; et al. A robotic multidimensional directed evolution approach applied to fluorescent voltage reporters. Nat. Chem. Biol. 2018, 14, 352–360. [Google Scholar] [CrossRef] [PubMed]
  210. Bohm, U.L.; Kimura, Y.; Kawashima, T.; Ahrens, M.B.; Higashijima, S.I.; Engert, F.; Cohen, A.E. Voltage imaging identifies spinal circuits that modulate locomotor adaptation in zebrafish. Neuron 2022, 110, 1211–1222.e4. [Google Scholar] [CrossRef] [PubMed]
  211. Beck, C.; Gong, Y. A high-speed, bright, red fluorescent voltage sensor to detect neural activity. Sci. Rep. 2019, 9, 15878. [Google Scholar] [CrossRef] [Green Version]
  212. Gong, Y.; Huang, C.; Li, J.Z.; Grewe, B.F.; Zhang, Y.; Eismann, S.; Schnitzer, M.J. High-speed recording of neural spikes in awake mice and flies with a fluorescent voltage sensor. Science 2015, 350, 1361–1366. [Google Scholar] [CrossRef] [Green Version]
  213. Kannan, M.; Vasan, G.; Huang, C.; Haziza, S.; Li, J.Z.; Inan, H.; Schnitzer, M.J.; Pieribone, V.A. Fast, in vivo voltage imaging using a red fluorescent indicator. Nat. Methods 2018, 15, 1108–1116. [Google Scholar] [CrossRef]
  214. Abdelfattah, A.S.; Kawashima, T.; Singh, A.; Novak, O.; Liu, H.; Shuai, Y.; Huang, Y.C.; Campagnola, L.; Seeman, S.C.; Yu, J.; et al. Bright and photostable chemigenetic indicators for extended in vivo voltage imaging. Science 2019, 365, 699–704. [Google Scholar] [CrossRef]
  215. Abdelfattah, A.S.; Zheng, J.; Singh, A.; Huang, Y.C.; Reep, D.; Tsegaye, G.; Tsang, A.; Arthur, B.J.; Rehorova, M.; Olson, C.V.L.; et al. Sensitivity optimization of a rhodopsin-based fluorescent voltage indicator. Neuron 2023, in press. [Google Scholar] [CrossRef] [PubMed]
  216. Abdelfattah, A.S.; Valenti, R.; Zheng, J.; Wong, A.; Team, G.P.; Podgorski, K.; Koyama, M.; Kim, D.S.; Schreiter, E.R. A general approach to engineer positive-going eFRET voltage indicators. Nat. Commun. 2020, 11, 3444. [Google Scholar] [CrossRef] [PubMed]
  217. Chanda, B.; Blunck, R.; Faria, L.C.; Schweizer, F.E.; Mody, I.; Bezanilla, F. A hybrid approach to measuring electrical activity in genetically specified neurons. Nat. Neurosci. 2005, 8, 1619–1626. [Google Scholar] [CrossRef] [PubMed]
  218. Grenier, V.; Daws, B.R.; Liu, P.; Miller, E.W. Spying on Neuronal Membrane Potential with Genetically Targetable Voltage Indicators. J. Am. Chem. Soc. 2019, 141, 1349–1358. [Google Scholar] [CrossRef]
  219. Inagaki, S.; Tsutsui, H.; Suzuki, K.; Agetsuma, M.; Arai, Y.; Jinno, Y.; Bai, G.; Daniels, M.J.; Okamura, Y.; Matsuda, T.; et al. Genetically encoded bioluminescent voltage indicator for multi-purpose use in wide range of bioimaging. Sci. Rep. 2017, 7, 42398. [Google Scholar] [CrossRef] [PubMed]
  220. Srinivasan, P.; Griffin, N.M.; Thakur, D.; Joshi, P.; Nguyen-Le, A.; McCotter, S.; Jain, A.; Saeidi, M.; Kulkarni, P.; Eisdorfer, J.T.; et al. An Autonomous Molecular Bioluminescent Reporter (AMBER) for Voltage Imaging in Freely Moving Animals. Adv. Biol. 2021, 5, e2100842. [Google Scholar] [CrossRef]
  221. Sternson, S.M.; Roth, B.L. Chemogenetic Tools to Interrogate Brain Functions. Annu. Rev. Neurosci. 2014, 37, 387–407. [Google Scholar] [CrossRef]
  222. Roth, B.L. DREADDs for Neuroscientists. Neuron 2016, 89, 683–694. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  223. Atasoy, D.; Sternson, S.M. Chemogenetic Tools for Causal Cellular and Neuronal Biology. Physiol. Rev. 2018, 98, 391–418. [Google Scholar] [CrossRef] [Green Version]
  224. Govorunova, E.G.; Sineshchekov, O.A.; Li, H.; Spudich, J.L. Microbial Rhodopsins: Diversity, Mechanisms, and Optogenetic Applications. Annu. Rev. Biochem. 2017, 86, 845–872. [Google Scholar] [CrossRef] [Green Version]
  225. Fenno, L.; Yizhar, O.; Deisseroth, K. The development and application of optogenetics. Annu. Rev. Neurosci. 2011, 34, 389–412. [Google Scholar] [CrossRef] [PubMed]
  226. Zhang, F.; Vierock, J.; Yizhar, O.; Fenno, L.E.; Tsunoda, S.; Kianianmomeni, A.; Prigge, M.; Berndt, A.; Cushman, J.; Polle, J.; et al. The microbial opsin family of optogenetic tools. Cell 2011, 147, 1446–1457. [Google Scholar] [CrossRef] [Green Version]
  227. Yizhar, O.; Fenno, L.; Zhang, F.; Hegemann, P.; Diesseroth, K. Microbial opsins: A family of single-component tools for optical control of neural activity. Cold Spring Harb. Protoc. 2011, 2011, top102. [Google Scholar] [CrossRef] [Green Version]
  228. Arrenberg, A.B.; Del Bene, F.; Baier, H. Optical control of zebrafish behavior with halorhodopsin. Proc. Natl. Acad. Sci. USA 2009, 106, 17968–17973. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  229. Ljunggren, E.E.; Haupt, S.; Ausborn, J.; Ampatzis, K.; El Manira, A. Optogenetic activation of excitatory premotor interneurons is sufficient to generate coordinated locomotor activity in larval zebrafish. J. Neurosci. 2014, 34, 134–139. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  230. Monesson-Olson, B.D.; Browning-Kamins, J.; Aziz-Bose, R.; Kreines, F.; Trapani, J.G. Optical stimulation of zebrafish hair cells expressing channelrhodopsin-2. PLoS ONE 2014, 9, e96641. [Google Scholar] [CrossRef] [Green Version]
  231. Harris, J.M.; Wang, A.Y.; Boulanger-Weill, J.; Santoriello, C.; Foianini, S.; Lichtman, J.W.; Zon, L.I.; Arlotta, P. Long-Range Optogenetic Control of Axon Guidance Overcomes Developmental Boundaries and Defects. Dev. Cell. 2020, 53, 577–588.e7. [Google Scholar] [CrossRef]
  232. Jeong, Y.-M.; Choi, T.-I.; Hwang, K.-S.; Lee, J.-S.; Gerlai, R.; Kim, C.-H. Optogenetic Manipulation of Olfactory Responses in Transgenic Zebrafish: A Neurobiological and Behavioral Study. Int. J. Mol. Sci. 2021, 22, 7191. [Google Scholar] [CrossRef]
  233. Arrenberg, A.B.; Stainier, D.Y.; Baier, H.; Huisken, J. Optogenetic control of cardiac function. Science 2010, 330, 971–974. [Google Scholar] [CrossRef] [PubMed]
  234. Kopton, R.A.; Baillie, J.S.; Rafferty, S.A.; Moss, R.; Zgierski-Johnston, C.M.; Prykhozhij, S.V.; Stoyek, M.R.; Smith, F.M.; Kohl, P.; Quinn, T.A.; et al. Cardiac Electrophysiological Effects of Light-Activated Chloride Channels. Front. Physiol. 2018, 9, 1806. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  235. Aramaki, T.; Kondo, S. Method for disarranging the pigment pattern of zebrafish by optogenetics. Dev. Biol. 2020, 460, 12–19. [Google Scholar] [CrossRef] [PubMed]
  236. Varady, A.; Distel, M. Non-neuromodulatory Optogenetic Tools in Zebrafish. Front. Cell. Dev. Biol. 2020, 8, 418. [Google Scholar] [CrossRef] [PubMed]
  237. Krueger, D.; Izquierdo, E.; Viswanathan, R.; Hartmann, J.; Pallares Cartes, C.; De Renzis, S. Principles and applications of optogenetics in developmental biology. Development 2019, 146, dev175067. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  238. Vardy, E.; Robinson, J.E.; Li, C.; Olsen, R.H.J.; DiBerto, J.F.; Giguere, P.M.; Sassano, F.M.; Huang, X.-P.; Zhu, H.; Urban, D.J.; et al. A New DREADD Facilitates the Multiplexed Chemogenetic Interrogation of Behavior. Neuron 2015, 86, 936–946. [Google Scholar] [CrossRef] [Green Version]
  239. Whissell, P.D.; Tohyama, S.; Martin, L.J. The Use of DREADDs to Deconstruct Behavior. Front. Genet. 2016, 7, 70. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  240. Mueller, J.S.; Tescarollo, F.C.; Sun, H. DREADDs in Epilepsy Research: Network-Based Review. Front. Mol. Neurosci. 2022, 15, 863003. [Google Scholar] [CrossRef] [PubMed]
  241. Gomez, J.L.; Bonaventura, J.; Lesniak, W.; Mathews, W.B.; Sysa-Shah, P.; Rodriguez, L.A.; Ellis, R.J.; Richie, C.T.; Harvey, B.K.; Dannals, R.F.; et al. Chemogenetics revealed: DREADD occupancy and activation via converted clozapine. Science 2017, 357, 503–507. [Google Scholar] [CrossRef] [Green Version]
  242. Bonaventura, J.; Eldridge, M.A.G.; Hu, F.; Gomez, J.L.; Sanchez-Soto, M.; Abramyan, A.M.; Lam, S.; Boehm, M.A.; Ruiz, C.; Farrell, M.R.; et al. High-potency ligands for DREADD imaging and activation in rodents and monkeys. Nat. Commun. 2019, 10, 4627. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  243. Nagai, Y.; Miyakawa, N.; Takuwa, H.; Hori, Y.; Oyama, K.; Ji, B.; Takahashi, M.; Huang, X.P.; Slocum, S.T.; DiBerto, J.F.; et al. Deschloroclozapine, a potent and selective chemogenetic actuator enables rapid neuronal and behavioral modulations in mice and monkeys. Nat. Neurosci. 2020, 23, 1157–1167. [Google Scholar] [CrossRef] [PubMed]
  244. Zhang, S.; Gumpper, R.H.; Huang, X.P.; Liu, Y.; Krumm, B.E.; Cao, C.; Fay, J.F.; Roth, B.L. Molecular basis for selective activation of DREADD-based chemogenetics. Nature 2022, 612, 354–362. [Google Scholar] [CrossRef] [PubMed]
  245. Goutaudier, R.; Coizet, V.; Carcenac, C.; Carnicella, S. DREADDs: The Power of the Lock, the Weakness of the Key. Favoring the Pursuit of Specific Conditions Rather than Specific Ligands. eNeuro 2019, 6, ENEURO.0171-19. [Google Scholar] [CrossRef] [Green Version]
  246. Urban, D.J.; Roth, B.L. DREADDs (designer receptors exclusively activated by designer drugs): Chemogenetic tools with therapeutic utility. Annu. Rev. Pharmacol. Toxicol. 2015, 55, 399–417. [Google Scholar] [CrossRef] [PubMed]
  247. Wang, L.; Zhu, L.; Meister, J.; Bone, D.B.J.; Pydi, S.P.; Rossi, M.; Wess, J. Use of DREADD Technology to Identify Novel Targets for Antidiabetic Drugs. Annu. Rev. Pharmacol. Toxicol. 2021, 61, 421–440. [Google Scholar] [CrossRef] [PubMed]
  248. Li, J.H.; Jain, S.; McMillin, S.M.; Cui, Y.; Gautam, D.; Sakamoto, W.; Lu, H.; Jou, W.; McGuinness, O.P.; Gavrilova, O.; et al. A novel experimental strategy to assess the metabolic effects of selective activation of a G(q)-coupled receptor in hepatocytes in vivo. Endocrinology 2013, 154, 3539–3551. [Google Scholar] [CrossRef] [Green Version]
  249. Chen, S.; Chiu, C.N.; McArthur, K.L.; Fetcho, J.R.; Prober, D.A. TRP channel mediated neuronal activation and ablation in freely behaving zebrafish. Nat. Methods 2016, 13, 147–150. [Google Scholar] [CrossRef]
  250. Silic, M.R.; Zhang, G. Tissue-specific modification of cellular bioelectrical activities using the chemogenetic tool, DREADD, in zebrafish. bioRxiv 2021. [Google Scholar] [CrossRef]
  251. Magnus, C.J.; Lee, P.H.; Bonaventura, J.; Zemla, R.; Gomez, J.L.; Ramirez, M.H.; Hu, X.; Galvan, A.; Basu, J.; Michaelides, M.; et al. Ultrapotent chemogenetics for research and potential clinical applications. Science 2019, 364, eaav5282. [Google Scholar] [CrossRef]
  252. Magnus, C.J.; Lee, P.H.; Atasoy, D.; Su, H.H.; Looger, L.L.; Sternson, S.M. Chemical and genetic engineering of selective ion channel-ligand interactions. Science 2011, 333, 1292–1296. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  253. Beckwith-Cohen, B.; Holzhausen, L.C.; Nawy, S.; Kramer, R.H. Controlling Horizontal Cell-Mediated Lateral Inhibition in Transgenic Zebrafish Retina with Chemogenetic Tools. eNeuro 2020, 7, ENEURO.0022-20. [Google Scholar] [CrossRef] [PubMed]
  254. Suster, M.L.; Kikuta, H.; Urasaki, A.; Asakawa, K.; Kawakami, K. Transgenesis in zebrafish with the tol2 transposon system. Methods Mol. Biol. 2009, 561, 41–63. [Google Scholar] [CrossRef] [PubMed]
  255. Boyden, E.S.; Zhang, F.; Bamberg, E.; Nagel, G.; Deisseroth, K. Millisecond-timescale, genetically targeted optical control of neural activity. Nat. Neurosci. 2005, 8, 1263–1268. [Google Scholar] [CrossRef] [PubMed]
  256. Zhang, C.; Yang, S.; Flossmann, T.; Gao, S.; Witte, O.W.; Nagel, G.; Holthoff, K.; Kirmse, K. Optimized photo-stimulation of halorhodopsin for long-term neuronal inhibition. BMC Biol. 2019, 17, 95. [Google Scholar] [CrossRef] [PubMed]
  257. Ganjawala, T.H.; Lu, Q.; Fenner, M.D.; Abrams, G.W.; Pan, Z.-H. Improved CoChR Variants Restore Visual Acuity and Contrast Sensitivity in a Mouse Model of Blindness under Ambient Light Conditions. Mol. Ther. 2019, 27, 1195–1205. [Google Scholar] [CrossRef] [PubMed]
  258. Ochs, A.R.; Karathanos, T.V.; Trayanova, N.A.; Boyle, P.M. Optogenetic Stimulation Using Anion Channelrhodopsin (GtACR1) Facilitates Termination of Reentrant Arrhythmias with Low Light Energy Requirements: A Computational Study. Front. Physiol. 2021, 12, 718622. [Google Scholar] [CrossRef]
  259. Mohamed, G.A.; Cheng, R.K.; Ho, J.; Krishnan, S.; Mohammad, F.; Claridge-Chang, A.; Jesuthasan, S. Optical inhibition of larval zebrafish behaviour with anion channelrhodopsins. BMC Biol. 2017, 15, 103. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  260. Malyshev, A.Y.; Roshchin, M.V.; Smirnova, G.R.; Dolgikh, D.A.; Balaban, P.M.; Ostrovsky, M.A. Chloride conducting light activated channel GtACR2 can produce both cessation of firing and generation of action potentials in cortical neurons in response to light. Neurosci. Lett. 2017, 640, 76–80. [Google Scholar] [CrossRef]
  261. Mahn, M.; Gibor, L.; Patil, P.; Cohen-Kashi Malina, K.; Oring, S.; Printz, Y.; Levy, R.; Lampl, I.; Yizhar, O. High-efficiency optogenetic silencing with soma-targeted anion-conducting channelrhodopsins. Nat. Commun. 2018, 9, 4125. [Google Scholar] [CrossRef] [Green Version]
  262. Alberio, L.; Locarno, A.; Saponaro, A.; Romano, E.; Bercier, V.; Albadri, S.; Simeoni, F.; Moleri, S.; Pelucchi, S.; Porro, A.; et al. A light-gated potassium channel for sustained neuronal inhibition. Nat. Methods 2018, 15, 969–976. [Google Scholar] [CrossRef]
  263. Hight, A.E.; Kozin, E.D.; Darrow, K.; Lehmann, A.; Boyden, E.; Brown, M.C.; Lee, D.J. Superior temporal resolution of Chronos versus channelrhodopsin-2 in an optogenetic model of the auditory brainstem implant. Hear. Res. 2015, 322, 235–241. [Google Scholar] [CrossRef] [Green Version]
  264. Krol, A.; Lopez-Huerta, V.G.; Corey, T.E.C.; Deisseroth, K.; Ting, J.T.; Feng, G. Two eARCHT3.0 Lines for Optogenetic Silencing of Dopaminergic and Serotonergic Neurons. Front. Neural Circuits 2019, 13, 4. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  265. Klapoetke, N.C.; Murata, Y.; Kim, S.S.; Pulver, S.R.; Birdsey-Benson, A.; Cho, Y.K.; Morimoto, T.K.; Chuong, A.S.; Carpenter, E.J.; Tian, Z.; et al. Independent optical excitation of distinct neural populations. Nat. Methods 2014, 11, 338–346. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  266. Weir, G.A.; Middleton, S.J.; Clark, A.J.; Daniel, T.; Khovanov, N.; McMahon, S.B.; Bennett, D.L. Using an engineered glutamate-gated chloride channel to silence sensory neurons and treat neuropathic pain at the source. Brain 2017, 140, 2570–2585. [Google Scholar] [CrossRef] [Green Version]
  267. Hobson, C.M.; Guo, M.; Vishwasrao, H.D.; Wu, Y.; Shroff, H.; Chew, T.L. Practical considerations for quantitative light sheet fluorescence microscopy. Nat. Methods 2022, 19, 1538–1549. [Google Scholar] [CrossRef] [PubMed]
  268. Park, O.K.; Kwak, J.; Jung, Y.J.; Kim, Y.H.; Hong, H.S.; Hwang, B.J.; Kwon, S.H.; Kee, Y. 3D Light-Sheet Fluorescence Microscopy of Cranial Neurons and Vasculature during Zebrafish Embryogenesis. Mol. Cells 2015, 38, 975–981. [Google Scholar] [CrossRef] [Green Version]
  269. Levin, M.; Martyniuk, C.J. The bioelectric code: An ancient computational medium for dynamic control of growth and form. Biosystems 2018, 164, 76–93. [Google Scholar] [CrossRef]
  270. Tseng, A.; Levin, M. Cracking the bioelectric code: Probing endogenous ionic controls of pattern formation. Commun. Integr. Biol. 2013, 6, e22595. [Google Scholar] [CrossRef]
  271. Silver, B.B.; Nelson, C.M. The Bioelectric Code: Reprogramming Cancer and Aging From the Interface of Mechanical and Chemical Microenvironments. Front. Cell. Dev. Biol. 2018, 6, 21. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  272. Wu, S.Y.; Wen, Y.; Serre, N.B.C.; Laursen, C.C.H.; Dietz, A.G.; Taylor, B.R.; Drobizhev, M.; Molina, R.S.; Aggarwal, A.; Rancic, V.; et al. A sensitive and specific genetically-encoded potassium ion biosensor for in vivo applications across the tree of life. PLoS Biol. 2022, 20, e3001772. [Google Scholar] [CrossRef]
  273. Lodovichi, C.; Ratto, G.M.; Trevelyan, A.J.; Arosio, D. Genetically encoded sensors for Chloride concentration. J. Neurosci. Methods 2022, 368, 109455. [Google Scholar] [CrossRef]
  274. Moresco, E.M.; Li, X.; Beutler, B. Going forward with genetics: Recent technological advances and forward genetics in mice. Am. J. Pathol. 2013, 182, 1462–1473. [Google Scholar] [CrossRef] [Green Version]
  275. Nusslein-Volhard, C.; Wieschaus, E. Mutations affecting segment number and polarity in Drosophila. Nature 1980, 287, 795–801. [Google Scholar] [CrossRef] [PubMed]
  276. Kutscher, L.M.; Shaham, S. Forward and reverse mutagenesis in C. elegans. WormBook 2014, 17, 1–26. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  277. Almen, M.S.; Nordstrom, K.J.; Fredriksson, R.; Schioth, H.B. Mapping the human membrane proteome: A majority of the human membrane proteins can be classified according to function and evolutionary origin. BMC Biol. 2009, 7, 50. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  278. O’Leary, T.; Williams, A.H.; Caplan, J.S.; Marder, E. Correlations in ion channel expression emerge from homeostatic tuning rules. Proc. Natl. Acad. Sci. USA 2013, 110, E2645–E2654. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  279. Kolodziejczyk, A.A.; Kim, J.K.; Svensson, V.; Marioni, J.C.; Teichmann, S.A. The technology and biology of single-cell RNA sequencing. Mol. Cell 2015, 58, 610–620. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  280. Jovic, D.; Liang, X.; Zeng, H.; Lin, L.; Xu, F.; Luo, Y. Single-cell RNA sequencing technologies and applications: A brief overview. Clin. Transl. Med. 2022, 12, e694. [Google Scholar] [CrossRef]
  281. Silic, M.R.; Black, M.M.; Zhang, G. Phylogenetic and developmental analyses indicate complex functions of calcium-activated potassium channels in zebrafish embryonic development. Dev. Dyn. 2021, 250, 1477–1493. [Google Scholar] [CrossRef] [PubMed]
  282. Silic, M.R.; Murata, S.H.; Park, S.J.; Zhang, G.J. Evolution of inwardly rectifying potassium channels and their gene expression in zebrafish embryos. Dev. Dynam 2022, 251, 687–713. [Google Scholar] [CrossRef] [PubMed]
  283. Yin, L.; Maddison, L.A.; Chen, W. Multiplex conditional mutagenesis in zebrafish using the CRISPR/Cas system. Methods Cell Biol. 2016, 135, 3–17. [Google Scholar] [CrossRef] [PubMed]
  284. Andersson-Rolf, A.; Mustata, R.C.; Merenda, A.; Kim, J.; Perera, S.; Grego, T.; Andrews, K.; Tremble, K.; Silva, J.C.; Fink, J.; et al. One-step generation of conditional and reversible gene knockouts. Nat. Methods 2017, 14, 287–289. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  285. Hans, S.; Zoller, D.; Hammer, J.; Stucke, J.; Spiess, S.; Kesavan, G.; Kroehne, V.; Eguiguren, J.S.; Ezhkova, D.; Petzold, A.; et al. Cre-Controlled CRISPR mutagenesis provides fast and easy conditional gene inactivation in zebrafish. Nat. Commun. 2021, 12, 1125. [Google Scholar] [CrossRef]
  286. Liu, F.; Kambakam, S.; Almeida, M.P.; Ming, Z.; Welker, J.M.; Wierson, W.A.; Schultz-Rogers, L.E.; Ekker, S.C.; Clark, K.J.; Essner, J.J.; et al. Cre/lox regulated conditional rescue and inactivation with zebrafish UFlip alleles generated by CRISPR-Cas9 targeted integration. eLife 2022, 11, e71478. [Google Scholar] [CrossRef]
  287. Wang, Y.; Hsu, A.Y.; Walton, E.M.; Park, S.J.; Syahirah, R.; Wang, T.; Zhou, W.; Ding, C.; Lemke, A.P.; Zhang, G.; et al. A robust and flexible CRISPR/Cas9-based system for neutrophil-specific gene inactivation in zebrafish. J. Cell Sci. 2021, 134, jcs258574. [Google Scholar] [CrossRef]
  288. Lee, R.T.; Knapik, E.W.; Thiery, J.P.; Carney, T.J. An exclusively mesodermal origin of fin mesenchyme demonstrates that zebrafish trunk neural crest does not generate ectomesenchyme. Development 2013, 140, 2923–2932. [Google Scholar] [CrossRef] [Green Version]
  289. Lee, R.T.; Thiery, J.P.; Carney, T.J. Dermal fin rays and scales derive from mesoderm, not neural crest. Curr. Biol. 2013, 23, R336–R337. [Google Scholar] [CrossRef] [Green Version]
  290. Levin, M.; Pietak, A.M.; Bischof, J. Planarian regeneration as a model of anatomical homeostasis: Recent progress in biophysical and computational approaches. Semin. Cell Dev. Biol. 2019, 87, 125–144. [Google Scholar] [CrossRef]
  291. Durant, F.; Bischof, J.; Fields, C.; Morokuma, J.; LaPalme, J.; Hoi, A.; Levin, M. The Role of Early Bioelectric Signals in the Regeneration of Planarian Anterior/Posterior Polarity. Biophys. J. 2019, 116, 948–961. [Google Scholar] [CrossRef] [Green Version]
  292. Rogers, K.W.; Schier, A.F. Morphogen gradients: From generation to interpretation. Annu. Rev. Cell Dev. Biol. 2011, 27, 377–407. [Google Scholar] [CrossRef] [Green Version]
  293. Tabata, T.; Takei, Y. Morphogens, their identification and regulation. Development 2004, 131, 703–712. [Google Scholar] [CrossRef] [Green Version]
  294. Pai, V.P.; Lemire, J.M.; Pare, J.F.; Lin, G.; Chen, Y.; Levin, M. Endogenous gradients of resting potential instructively pattern embryonic neural tissue via Notch signaling and regulation of proliferation. J. Neurosci. 2015, 35, 4366–4385. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  295. Belus, M.T.; Rogers, M.A.; Elzubeir, A.; Josey, M.; Rose, S.; Andreeva, V.; Yelick, P.C.; Bates, E.A. Kir2.1 is important for efficient BMP signaling in mammalian face development. Dev. Biol. 2018, 444 (Suppl. S1), S297–S307. [Google Scholar] [CrossRef] [PubMed]
  296. Dahal, G.R.; Rawson, J.; Gassaway, B.; Kwok, B.; Tong, Y.; Ptáček, L.J.; Bates, E. An inwardly rectifying K+ channel is required for patterning. Development 2012, 139, 3653–3664. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  297. Dahal, G.R.; Pradhan, S.J.; Bates, E.A. Inwardly rectifying potassium channels influence Drosophila wing morphogenesis by regulating Dpp release. Development 2017, 144, 2771–2783. [Google Scholar] [CrossRef] [Green Version]
  298. Muccioli, S.; Brillo, V.; Chieregato, L.; Leanza, L.; Checchetto, V.; Costa, R. From Channels to Canonical Wnt Signaling: A Pathological Perspective. Int. J. Mol. Sci. 2021, 22, 4613. [Google Scholar] [CrossRef] [PubMed]
  299. Delling, M.; DeCaen, P.G.; Doerner, J.F.; Febvay, S.; Clapham, D.E. Primary cilia are specialized calcium signalling organelles. Nature 2013, 504, 311–314. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  300. DeCaen, P.G.; Delling, M.; Vien, T.N.; Clapham, D.E. Direct recording and molecular identification of the calcium channel of primary cilia. Nature 2013, 504, 315–318. [Google Scholar] [CrossRef] [Green Version]
  301. Emmons-Bell, M.; Hariharan, I.K. Membrane potential regulates Hedgehog signalling in the Drosophila wing imaginal disc. EMBO Rep. 2021, 22, e51861. [Google Scholar] [CrossRef]
  302. Petrov, K.; Wierbowski, B.M.; Liu, J.; Salic, A. Distinct Cation Gradients Power Cholesterol Transport at Different Key Points in the Hedgehog Signaling Pathway. Dev. Cell 2020, 55, 314–327.e7. [Google Scholar] [CrossRef] [PubMed]
  303. Myers, B.R.; Neahring, L.; Zhang, Y.; Roberts, K.J.; Beachy, P.A. Rapid, direct activity assays for Smoothened reveal Hedgehog pathway regulation by membrane cholesterol and extracellular sodium. Proc. Natl. Acad. Sci. USA 2017, 114, E11141–E11150. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Figure 1. Cell membrane potential formation and comparison of neuromuscular excitable cells and non-excitable somatic cells. (A). Illustration of resting membrane potential, ion regulators, and ionic concentrations when the cell is in a non-excitable state. Different shapes represent various ion regulators on a cell membrane (blue region). The arrows indicate the movement of ions when the regulators are open. (B). Comparison of neuromuscular excitable and non-excitable somatic cells. Excitable cells usually exhibit action potentials, while the non-excitable somatic cells have membrane potential fluctuations, which vary in their amplitudes and frequencies.
Figure 1. Cell membrane potential formation and comparison of neuromuscular excitable cells and non-excitable somatic cells. (A). Illustration of resting membrane potential, ion regulators, and ionic concentrations when the cell is in a non-excitable state. Different shapes represent various ion regulators on a cell membrane (blue region). The arrows indicate the movement of ions when the regulators are open. (B). Comparison of neuromuscular excitable and non-excitable somatic cells. Excitable cells usually exhibit action potentials, while the non-excitable somatic cells have membrane potential fluctuations, which vary in their amplitudes and frequencies.
Cells 12 01148 g001
Figure 2. Illustrations of design principles of common GEVIs, optogenetic and chemogenetic tools. (A). Schematic structures of VSD (voltage sensitive domain) based and opsin-based GEVIs. The voltage-sensitive domain is labeled brown in the cell membrane. A fluorescent protein (FP) is inserted into the S3–S4 loop. When Vm is altered, the fluorescence intensity will change accordingly. The light-sensitive opsin (dark blue) can sense the Vm of the membrane and act as a chromophore. Thus, it can be used to measure the Vm with or without a connected FP, which can enhance the overall signal. (B). Principles of Optogenetics and chemogenetics. The optogenetic tools are based on light-sensitive channel rhodopsins that conduct protons or chloride. The PSAMs are mutated ligand-gated ion channels for sodium or chloride. They are controlled by artificial PSEM (pharmacologically selective effector molecules) ligands. In contrast, the DREADDs are mutated ligand-gated GPCRs (G-protein-coupled receptors). Depending on the type of G protein, they can increase or decrease Vm via GIRK channels, calcium signaling, and cAMPs. The arrows indicate the movement of ions when the regulators are open.
Figure 2. Illustrations of design principles of common GEVIs, optogenetic and chemogenetic tools. (A). Schematic structures of VSD (voltage sensitive domain) based and opsin-based GEVIs. The voltage-sensitive domain is labeled brown in the cell membrane. A fluorescent protein (FP) is inserted into the S3–S4 loop. When Vm is altered, the fluorescence intensity will change accordingly. The light-sensitive opsin (dark blue) can sense the Vm of the membrane and act as a chromophore. Thus, it can be used to measure the Vm with or without a connected FP, which can enhance the overall signal. (B). Principles of Optogenetics and chemogenetics. The optogenetic tools are based on light-sensitive channel rhodopsins that conduct protons or chloride. The PSAMs are mutated ligand-gated ion channels for sodium or chloride. They are controlled by artificial PSEM (pharmacologically selective effector molecules) ligands. In contrast, the DREADDs are mutated ligand-gated GPCRs (G-protein-coupled receptors). Depending on the type of G protein, they can increase or decrease Vm via GIRK channels, calcium signaling, and cAMPs. The arrows indicate the movement of ions when the regulators are open.
Cells 12 01148 g002
Figure 3. Summary and perspectives of bioelectricity in zebrafish developmental patterning research. Bioelectricity may function in zebrafish early embryos for patterning adult tissue/organs. Multiple ion regulators exist in each cell, so the cell’s bioelectric properties are generally robust. Minor disruptions (smaller lightning arrows) are not enough to change the bioelectric status quo, and only significant changes (big lightning arrows) may break through the robustness. This may explain why most zebrafish mutants were found with GOF (gain-of-function), DN (dominant negative), and ectopic expressions. Mechanistically, this bioelectric patterning may interact with already-known morphogen proteins and transcription factors. However, most likely, there are unknown mechanisms that mediate this bioelectric patterning. Next-generation sequencing technologies and CRISPR genome editing may help decipher such novel mechanisms. In addition, the recently developed genetically encoded tools for neuroscience, such as GEVIs, optogenetics, and chemogenetics, are readily adopted to the embryonic patterning research field. These tools allow us to monitor and manipulate bioelectricity in a non-invasive manner.
Figure 3. Summary and perspectives of bioelectricity in zebrafish developmental patterning research. Bioelectricity may function in zebrafish early embryos for patterning adult tissue/organs. Multiple ion regulators exist in each cell, so the cell’s bioelectric properties are generally robust. Minor disruptions (smaller lightning arrows) are not enough to change the bioelectric status quo, and only significant changes (big lightning arrows) may break through the robustness. This may explain why most zebrafish mutants were found with GOF (gain-of-function), DN (dominant negative), and ectopic expressions. Mechanistically, this bioelectric patterning may interact with already-known morphogen proteins and transcription factors. However, most likely, there are unknown mechanisms that mediate this bioelectric patterning. Next-generation sequencing technologies and CRISPR genome editing may help decipher such novel mechanisms. In addition, the recently developed genetically encoded tools for neuroscience, such as GEVIs, optogenetics, and chemogenetics, are readily adopted to the embryonic patterning research field. These tools allow us to monitor and manipulate bioelectricity in a non-invasive manner.
Cells 12 01148 g003
Table 1. Reported cellular membrane potential of common vertebrate cell types.
Table 1. Reported cellular membrane potential of common vertebrate cell types.
Somatic CellsEmbryonic OriginMillivolts (mV)References
Skeletal myocyteParaxial mesodermFrom −91 to −65[42]
Heart myocyteLateral plate mesodermFrom −95 to −40[43]
Gut smooth muscle myocyteLateral plate mesodermFrom −70 to −35[44]
GliocyteNeuroectoderm or neural crestAbout −80[45]
NeuronNeuroectodermFrom −85 to −65[46,47]
Adrenal cortexIntermediate mesodermFrom −71 to −66[48]
Adrenal medullaNeural crestFrom −32 to −20[48]
LymphocyteMesodermFrom −70 to −50[49]
Thyroid follicular cellForegut endodermFrom −70 to −60[50]
ChondrocyteMesoderm and neural crestFrom −64 to −48[51]
FibroblastAll three embryological germ layersFrom −25 to −16[52,53]
Liver hepatocyteVentral foregut endodermFrom −50 to −20[54]
Pancreas β-cellForegut endodermFrom −80 to −60[35]
Epithelial cellAll three embryological germ layersFrom −70 to −20[55]
MelanocyteNeural crestFrom −50 to −40[56,57,58]
White adipocyteMesoderm and neuroectodermFrom −69 to −17[59]
OsteocytesMesoderm and neural crestAbout −60[60]
Cancer and tumor cells All three embryological germ layersFrom −50 to −5[10,56,61,62]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Silic, M.R.; Zhang, G. Bioelectricity in Developmental Patterning and Size Control: Evidence and Genetically Encoded Tools in the Zebrafish Model. Cells 2023, 12, 1148. https://doi.org/10.3390/cells12081148

AMA Style

Silic MR, Zhang G. Bioelectricity in Developmental Patterning and Size Control: Evidence and Genetically Encoded Tools in the Zebrafish Model. Cells. 2023; 12(8):1148. https://doi.org/10.3390/cells12081148

Chicago/Turabian Style

Silic, Martin R., and GuangJun Zhang. 2023. "Bioelectricity in Developmental Patterning and Size Control: Evidence and Genetically Encoded Tools in the Zebrafish Model" Cells 12, no. 8: 1148. https://doi.org/10.3390/cells12081148

APA Style

Silic, M. R., & Zhang, G. (2023). Bioelectricity in Developmental Patterning and Size Control: Evidence and Genetically Encoded Tools in the Zebrafish Model. Cells, 12(8), 1148. https://doi.org/10.3390/cells12081148

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop